Читать книгу Genetic Disorders and the Fetus - Группа авторов - Страница 139

1 1. Parkin FM, Lind T, Cheyne GA. Biochemical and cytological changes in liquor amnii with advancing gestation. J Obstet Gynaecol Br Commonw 1969; 76:673.

2 2. Lind T, Hytten FE. Relation of amniotic fluid volume to fetal weight in the first half of pregnancy. Lancet 1970; i:1147.

3 3. Bourne GL. The anatomy of the human amnion and chorion. Proc R Soc Med 1966; 59:1127.

4 4. Bourne GL. The human amnion and chorion. London: Lloyd‐Luke, 1962.

5 5. Behrman RE, Parer JT, De Lannoy CW, Jr. Placental growth and the formation of amniotic fluid. Nature 1967; 214:678.

6 6. Seeds AEJ. Dynamics of amniotic fluid. In: Natelson S, Scommegna A, Epstein MB, eds. Amniotic fluid. New York: Wiley, 1974:23.

7 7. Nicolini U, Fisk NM, Talbert DG, et al. Intrauterine manometry: technique and application to fetal pathology. Prenat Diagn 1989; 9:243.

8 8. Fisk NM, Ronderos‐Dumit D, Tannirandorn Y, et al. Normal amniotic pressure throughout gestation. Br J Obstet Gynaecol 1992; 99:18.

9 9. Barbera A, Buscaglia M, Ferrazzi E, et al. Intra‐amniotic pressure is not affected by amniocentesis between 13 and 18 weeks of gestation. Eur J Obstet Gynecol Reprod Biol 1993; 50:185.

10 10. Hutchinson DL, Hunter CB, Neslen ED, et al. The exchange of water and electrolytes in the mechanism of amniotic fluid formation and the relationship to hydramnios. Surg Gynecol Obstet 1955; 100:391.

11 11. Pritchard JA. Deglutition by normal and anencephalic fetuses. Obstet Gynecol 1965; 25:289.

12 12. Hutchinson DL, Gray MJ, Plentl AA, et al. The role of the fetus in the water exchange of the amniotic fluid of normal and hydramniotic patients. J Clin Invest 1959; 38:971.

13 13. Gulbis B, Jauniaux E, Jurkovic D, et al. Biochemical investigation of fetal renal maturation in early pregnancy. Pediatr Res 1996; 39:731.

14 14. Thomas CR, Lang EK, Lloyd FP. Fetal pyelography – a method for detecting fetal life. A preliminary report. Obstet Gynecol 1963; 22:335.

15 15. Hibbard BM. Polyhydramnios and oligohydramnios. Clin Obstet Gynecol 1962; 5:1044.

16 16. Brace RA. Amniotic fluid volume and its relationship to fetal fluid balance: review of experimental data. Semin Perinatol 1986; 10:103.

17 17. Lotgering FK,Wallenburg HC. Mechanisms of production and clearance of amniotic fluid. Semin Perinatol 1986; 10:94.

18 18. Tervilae L. Transfer of water from maternal blood to amniotic fluid of live and dead fetuses in health and in some pathological conditions of the mother. A study with tritium‐labelled water. Ann Chir Gynaecol Fenn 1964; 53:1.

19 19. Bourne GL, Lacy D. Ultra‐structure of human amnion and its possible relation to the circulation of amniotic fluid. Nature 1960; 186:952.

20 20. Wintour EM, Shandley L. Effects of fetal fluid balance on amniotic fluid volume. Semin Perinatol 1993; 17: 158.

21 21. Gray MJ, Neslen ED, Plentl AA. Estimation of water transfer from amniotic fluid to fetus. Proc Soc Exp Biol Med 1956; 92:463.

22 22. Abramovich DR. Fetal factors influencing the volume and composition of liquor amnii. J Obstet Gynaecol Br Commonw 1970; 77:865.

23 23. Chamberlain P. Amniotic fluid volume: ultrasound assessment and clinical significance. Semin Perinatol 1985; 9:163.

24 24. Kurjak A, Kirkinen P, Latin V, et al. Ultrasonic assessment of fetal kidney function in normal andcomplicated pregnancies. Am J Obstet Gynecol 1981; 141:266.

25 25. Weiner CP, Grose C. Prenatal diagnosis of congenital cytomegalovirus infection by virus isolation from amniotic fluid. Am J Obstet Gynecol 1990; 163:1253.

26 26. Ostergard DR. The physiology and clinical importance of amniotic fluid. A review. Obstet Gynecol Surv 1970; 25:297.

27 27. Fuchs F. Volume of amniotic fluid at various stages of pregnancy. Clin Obstet Gynecol 1966; 9:449.

28 28. Nelson MM. Amniotic fluid volumes in early pregnancy. J Obstet Gynaecol Br Commonw 1972; 79:50.

29 29. Wagner G, Fuchs F. The volume of amniotic fluid in the first half of human pregnancy. J Obstet Gynaecol Br Emp 1962; 69:131.

30 30. Rhodes P. The volume of liquor amnii in early pregnancy. J Obstet Gynaecol Br Commonw 1966; 73:23.

31 31. Abramovich DR. The volume of amniotic fluid in early pregnancy. J Obstet Gynaecol Br Commonw 1968; 75:728.

32 32. Queenan JT, Thompson W, Whitfield CR, et al. Amniotic fluid volumes in normal pregnancies. Am J Obstet Gynecol 1972; 114:34.

33 33. Moore TR. Clinical evaluation of amniotic fluid volume. Semin Perinatol 1993; 17:173.

34 34. Larmon JE, Ross BS. Clinical utility of amniotic fluid volume assessment. Obstet Gynecol Clin North Am 1998; 25:639.

35 35. Magann EF, Chauhan SP, Doherty DA, et al. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv 2007; 62:795.

36 36. Lu SC, Chang CH, Yu CH, et al. Reappraisal of normal amniotic fluid index in an Asian population: analysis of 27,088 records. Taiwan J Obstet Gynecol 2007; 46: 260.

37 37. Sandlin AT, Ounpraseuth ST, Spencer HJ, et al. Amniotic fluid volume in normal singleton pregnancies: modeling with quantile regression. Arch Gynecol Obstet 2014; 289:967.

38 38. Barrilleaux PS, Magann EF, Chauhan SP, et al. Amniotic fluid index as a predictor of adverse perinatal outcome in the HELLP syndrome. J Reprod Med 2007; 52:293.

39 39. Morris RK, Meller CH, Tamblyn J, et al. Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta‐analysis. BJOG 2014; 121:686.

40 40. Stevenson AC, Davison BCC, Oakes MW. Genetic counselling, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 1976.

41 41. Moise KJ, Jr. Toward consistent terminology: assessment and reporting of amniotic fluid volume. Semin Perinatol 2013; 37:370.

42 42. Beischer N, Desmedt E, Ratten G, et al. The significance of recurrent polyhydramnios. Aust N Z J Obstet Gynecol 1993; 33:25.

43 43. Scott JS. The volume and circulation of the liquor amnii: clinical observations. Proc R Soc Med 1966; 59:1128.

44 44. Esplin MS, Hallam S, Farrington PF, et al. Myotonic dystrophy is a significant cause of idiopathic polyhydramnios. Am J Obstet Gynecol 1998; 179:974.

45 45. Benirschke K, McKay DG. The antidiuretic hormone in fetus and infant; histochemical observations with special reference to amniotic fluid formation. Obstet Gynecol 1953; 1:638.

46 46. Potter EL. Bilateral absence of ureters and kidneys: a report of 50 cases. Obstet Gynecol 1965; 25:3.

47 47. Spaggiari E, Heidet L, Grange G, et al. Prognosis and outcome of pregnancies exposed to renin‐angiotensin system blockers. Prenat Diagn 2012; 32:1071.

48 48. Sherer DM. A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios. Am J Perinatol 2002; 19:253.

49 49. Voxman EG, Tran S, Wing DA. Low amniotic fluid index as a predictor of adverse perinatal outcome. J Perinatol 2002; 22:282.

50 50. HellstromWJ, Kogan BA, Jeffrey RB, Jr., et al. The natural history of prenatal hydronephrosis with normal amounts of amniotic fluid. J Urol 1984; 132:947.

51 51. Sutcliffe RG. The nature and origin of the soluble protein in human amniotic fluid. Biol Rev Camb Philos Soc 1975; 50:1.

52 52. Sutcliffe RG, Brock DJ. Immunological studies on the nature and origin of the major proteins in amniotic fluid. J Obstet Gynaecol Br Commonw 1973; 80:721.

53 53. Gitlin D, Kumate J, Urrusti J, et al. The selectivity of the human placenta in the transfer of plasma proteins from mother to fetus. J Clin Invest 1964; 43:1938.

54 54. Baardman ME, Erwich JJ, Berger RM, et al. The origin of fetal sterols in second‐trimester amniotic fluid: endogenous synthesis or maternal–fetal transport? Am J Obstet Gynecol 2012; 207:202 e19.

55 55. Muller‐Eberhard U, Bashore R. Assessment of Rh disease by ratios of bilirubin to albumin and hemopexin to albumin in amniotic fluid. N Engl J Med 1970; 282:1163.

56 56. Johnson AM, Umansky I, Alper CA, et al. Amniotic fluid proteins: maternal and fetal contributions. J Pediatr 1974; 84:588.

57 57. Heikinheimo M, Jalanko H, Leisti J, et al. Amniotic fluid pregnancy‐specific beta 1‐glycoprotein (SP1) in fetal developmental disorders. Prenat Diagn 1984; 4:147.

58 58. Jorgensen OS, Norgaard‐Pedersen B. The synaptic membrane D2‐protein in amniotic fluid from pregnancies with fetal neural tube defects. Prenat Diagn 1981; 1:3.

59 59. Sindic CJ, Freund M, Van Regemorter N, et al. S‐100 protein in amniotic fluid of anencephalic fetuses. Prenat Diagn 1984; 4:297.

60 60. Anneren G, Esscher T, Larsson L, et al. S‐100 protein and neuron‐specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus. Prenat Diagn 1988; 8:323.

61 61. Gogiel T, Bielecki DA, Bankowski E. Collagenous constituents of amniotic fluid. Acta Biochim Pol 1998; 45:1037.

62 62. Uyeno D. The physical properties and chemical composition of human amniotic fluid. J Biol Chem 1919; 37:77.

63 63. Campbell J, Wathen N, Macintosh M, et al. Biochemical composition of amniotic fluid and extraembryonic coelomic fluid in the first trimester of pregnancy. Br J Obstet Gynaecol 1992; 99:563.

64 64. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008; 105:20458.

65 65. Hui L, Wick HC, Edlow AG, et al. Global gene expression analysis of term amniotic fluid cell‐free fetal RNA. Obstet Gynecol 2013; 121:1248.

66 66. Salafsky IS, Nadler HL. Intracellular organelles and enzymes in cell‐free amniotic fluid. Am J Obstet Gynecol 1971; 111:1046.

67 67. Risteli L, Autio‐Harmainen H, von Koskull H, et al. Basement membrane proteins in human amniotic fluid. Clin Genet 1984; 26:271.

68 68. Phimister GM, Marshall RD. Tamm‐Horsfall glycoprotein in human amniotic fluid. Clin Chim Acta 1983; 128:261.

69 69. Lee TY, Schafer IA. Glycosaminoglycan composition of human amniotic fluid. Biochim Biophys Acta 1974; 354:264.

70 70. Duncan DM, Logan RW, Ferguson‐Smith MA, et al. The measurement of acid mucopolysaccharides (glycosaminoglycans) in amniotic fluid and urine. Clin Chim Acta 1973; 45:73.

71 71. Thompson AR. Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis. Blood 1984; 64:867.

72 72. Queenan JT, Gadow EC, Bachner P, et al. Amniotic fluid proteins in normal and Rh‐sensitized pregnancies. Am J Obstet Gynecol 1970; 108:406.

73 73. Jauniaux E,Gulbis B, Hyett J, et al. Biochemical analyses of mesenchymal fluid in early pregnancy. Am J Obstet Gynecol 1998; 178:765.

74 74. Lambotte R, Uhlenbruck G. Amniomucoids – a new class of hexosamine‐rich glycoproteins. Nature 1966; 212:290.

75 75. Lambotte R, Gosselin‐Ray C. Analyse électrophorétique de la teneur en polysaccharides de l'α1 globuline spécifique au liquide amniotique humain. Arch Int Physiol Biochim Biophys 1967; 75:109.

76 76. Chitayat D, Marion RW, Squillante L, et al. Detection and enumeration of colonic mucosal cells in amniotic fluid using a colon epithelial‐specific monoclonal antibody. Prenat Diagn 1990; 10:725.

77 77. Friel LA, Romero R, Edwin S, et al. The calcium binding protein, S100B, is increased in the amniotic fluid of women with intra‐amniotic infection/inflammation and preterm labor with intact or ruptured membranes. J Perinat Med 2007; 35:385.

78 78. Tskitishvili E, Komoto Y, Temma‐Asano K, et al. S100B protein expression in the amnion and amniotic fluid in pregnancies complicated by pre‐eclampsia. Mol Hum Reprod 2006; 12:755.

79 79. Florio P, Michetti F, Bruschettini M, et al. Amniotic fluid S100B protein in mid‐gestation and intrauterine fetal death. Lancet 2004; 364:270.

80 80. Cho CK, Shan SJ, Winsor EJ, et al. Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 2007; 6:1406.

81 81. Michaels JE, Dasari S, Pereira L, et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age‐dependent changes. J Proteome Res 2007; 6:1277.

82 82. Buhimschi CS, Buhimschi IA, Abdel‐Razeq S, et al. Proteomic biomarkers of intra‐amniotic inflammation: relationship with funisitis and early‐onset sepsis in the premature neonate. Pediatr Res 2007; 61:318.

83 83. Buhimschi IA, Zhao G, Rosenberg VA, et al. Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth. PLoS One 2008; 3:e2049.

84 84. Kamath‐Rayne BD, Smith HC, Muglia LJ, et al. Amniotic fluid: the use of high‐dimensional biology to understand fetal well‐being. Reprod Sci 2014; 21:6.

85 85. Wang TH, Chang YL, Peng HH, et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat Diagn 2005; 25:559.

86 86. Hassan MI, Kumar V, Singh TP, et al. Proteomic analysis of human amniotic fluid from Rh(−) pregnancy. Prenat Diagn 2008; 28:102.

87 87. Biezenski JJ. Incorporation of 14C‐1‐palmitate into rabbit fetal lipids in vivo. Am J Obstet Gynecol 1976; 126:356.

88 88. Robertson AF, Sprecher H. A review of human placental lipid metabolism and transport. Acta Paediatr Scand 1968:Suppl 183:3.

89 89. Pomerance W, Biezenski JJ, Moltz A, et al. Origin of amniotic fluid lipids. II. Abnormal pregnancy. Obstet Gynecol 1971; 38:379.

90 90. Gardella C, Hitti J, Martin TR, et al. Amniotic fluid lipopolysaccharide‐binding protein and soluble CD14 as mediators of the inflammatory response in preterm labor. Am J Obstet Gynecol 2001; 184:1241.

91 91. Dallaire L, Mitchell G, Giguere R, et al. Prenatal diagnosis of Smith‐Lemli‐Opitz syndrome is possible by measurement of 7‐dehydrocholesterol in amniotic fluid. Prenat Diagn 1995; 15:855.

92 92. Tint GS, Abuelo D, Till M, et al. Fetal Smith‐Lemli‐ Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols. Prenat Diagn 1998; 18:651.

93 93. Wassif CA, Maslen C, Kachilele‐Linjewile S, et al. Mutations in the human sterol delta7‐reductase gene at 11q12‐13 cause Smith‐Lemli‐Opitz syndrome. Am J Hum Genet 1998; 63:55.

94 94. Loeffler J, Utermann G, Witsch‐Baumgartner M. Molecular prenatal diagnosis of Smith‐Lemli‐Opitz syndrome is reliable and efficient. Prenat Diagn 2002; 22:827.

95 95. Waye JS, Eng B, Nowaczyk MJ. Prenatal diagnosis of Smith‐Lemli‐Opitz syndrome (SLOS) by DHCR7 mutation analysis. Prenat Diagn 2007; 27:638.

96 96. Shinawi M, Szabo S, Popek E, et al. Recognition of Smith‐Lemli‐Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol. Am J Med Genet A 2005; 138:56.

97 97. Chevy F, Humbert L, Wolf C. Sterol profiling of amniotic fluid: a routine method for the detection of distal cholesterol synthesis deficit. Prenat Diagn 2005; 25:1000.

98 98. Fitzky BU, Witsch‐Baumgartner M, Erdel M, et al. Mutations in the Delta7‐sterol reductase gene in patients with the Smith‐Lemli‐Opitz syndrome. Proc Natl Acad Sci U S A 1998; 95:8181.

99 99. Yu H, Lee MH, Starck L, et al. Spectrum of delta(7)‐dehydrocholesterol reductase mutations in patients with the Smith‐Lemli‐Opitz (RSH) syndrome. Hum Mol Genet 2000; 9:1385.

100 100. Yu H, Tint GS, Salen G, et al. Detection of a common mutation in the RSH or Smith‐Lemli‐Opitz syndrome by a PCR‐RFLP assay: IVS8‐G→C is found in over sixty percent of US propositi. Am J Med Genet 2000; 90:347.

101 101. Haas D, Haege G, Hoffmann GF, et al. Prenatal presentation and diagnostic evaluation of suspected Smith‐Lemli‐Opitz (RSH) syndrome. Am J Med Genet A 2013; 161A:1008.

102 102. Goldenberg A, Wolf C, Chevy F, et al. Antenatal manifestations of Smith‐Lemli‐Opitz (RSH) syndrome: a retrospective survey of 30 cases. Am J Med Genet A 2004; 124A:423.

103 103. Hagenfeldt L, Hagenfeldt K. Individual free fatty acids in amniotic fluid and in plasma of pregnant women. Br J Obstet Gynaecol 1976; 83:383.

104 104. Rueda R, Vargas ML, Garcia‐Pacheco M, et al. Detection of immunoregulatory lipid‐like factors in human amniotic fluid. Am J Reprod Immunol 1990; 24:40.

105 105. Heikkinen J, Maentausta O, Tuimala R, et al. Amniotic fluid bile acids in normal and pathologic pregnancy. Obstet Gynecol 1980; 56:60.

106 106. Deleze G, Sidiropoulos D, Paumgartner G. Determination of bile acid concentration in human amniotic fluid for prenatal diagnosis of intestinal obstruction. Pediatrics 1977; 59:647.

107 107. Shrand H. Vomiting in utero with intestinal atresia. Pediatrics 1972; 49:767.

108 108. Gluck L, Kulovich MV. Lecithin‐sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 1973; 115:539.

109 109. Gluck L. Surfactant: 1972. Pediatr Clin North Am 1972; 19:325.

110 110. Briand RL, Harold S, Blass KG. High‐performance liquid chromatographic determination of the lecithin/sphingomyelin ratio in amniotic fluid. J Chromatogr 1981; 223:277.

111 111. Ghidini A, Poggi SH, Spong CY, et al. Role of lamellar body count for the prediction of neonatal respiratory distress syndrome in non‐diabetic pregnant women. Arch Gynecol Obstet 2005; 271:325.

112 112. Karcher R, Sykes E, Batton D, et al. Gestational age specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant‐to‐albumin ratio in amniotic fluid. Am J Obstet Gynecol 2005; 193:1680.

113 113. ACOG Committee opinion no. 560: Medically indicated late‐preterm and early‐term deliveries. Obstet Gynecol 2013; 121:908.

114 114. Damron DP. Fetal lung maturity testing. Am J Obstet Gynecol 2014; 211:184.

115 115. Southren AL, Kobayashi Y, Brenner P, et al. Diamine oxidase activity in human maternal and fetal plasma and tissues at parturition. J Appl Physiol 1965; 20:1048.

116 116. Lapan B, Friedman MM. Enzymes in the amniotic fluid and maternal serum. A comparative study. Am J Obstet Gynecol 1962; 83:1337.

117 117. Usategui‐Gomez M. Immunoglobulins and other proteins in amniotic fluid. In: Natelson S, Scommegna A, Epstein MB, eds. Amniotic fluid. New York: Wiley, 1974:111.

118 118. Uuspaa VJ. High histaminase activity of human blood in pregnancy and the so‐called placenta haemochorialis: preliminary report. Ann Med Exp Biol Fenn 1951; 29:81.

119 119. Kerenyi T, Sarkozi L. Diagnosis of fetal death in utero by elevated amniotic fluid CPK levels. Obstet Gynecol 1974; 44:215.

120 120. Geyer H, Schneider I. Enzyme in Fruchtwasser [Enzymes of amniotic fluid]. Z Klin Chem Klin Biochem 1970; 8:141.

121 121. Geyer H. Zie herkunft der Fruchtwasser‐enzyme [The origin of amniotic fluid enzymes]. Z Klin Chem Klin Biochem 1970; 8:145.

122 122. Potier M, Dallaire L, Melancon SB. Amniotic fluid alpha‐galactosidase activity: an indicator of gestational age. Gynecol Invest 1974; 5:306.

123 123. Bacigalupo G, Meraner R. Pyruvate kinase in human amniotic fluid – a new indicator of fetal maturity in late pregnancy. J Perinat Med 1984; 12:97.

124 124. Brocklehurst D, Wilde CE. Amniotic fluid alkaline phosphatase, gamma‐glutamyltransferase, and 5′‐nucleotidase activity from 13 to 40 weeks' gestation, and alkaline phosphatase as an index of fetal lung maturity. Clin Chem 1980; 26:588.

125 125. Gurdol F, Genc S, Yalcin O, et al. The presence of prolidase activity in amniotic fluid and its evaluation as a maturity test. Biol Neonate 1995; 67:34.

126 126. Butterworth J, Broadhead DM, Sutherland GR, et al. Lysosomal enzymes of amniotic fluid in relation to gestational age. Am J Obstet Gynecol 1974; 119:821.

127 127. Parmley TH, Seeds AE. Fetal skin permeability to isotopic water (THO) in early pregnancy. Am J Obstet Gynecol 1970; 108:128.

128 128. Lind T, Kendall A, Hytten FE. The role of the fetus in the formation of amniotic fluid. J Obstet Gynaecol Br Commonw 1972; 79:289.

129 129. Fluharty AL, Scott ML, Porter MT, et al. Acid alpha‐glucosidase in amniotic fluid. Biochem Med 1973; 7:39.

130 130. Potier M, Dallaire L, Melancon SB. Occurrence and properties of fetal intestinal glycosidases (disaccharidases) in human amniotic fluid. Biol Neonate 1975; 27:141.

131 131. Antonowicz I, Milunsky A, Lebenthal E, et al. Disaccharidase and lysosomal enzyme activities in amniotic fluid, intestinal mucosa and meconium. Correlation between morphology and disaccharidase activities in human fetal small intestine. Biol Neonate 1977; 32: 280.

132 132. Nadler HL, Messina AM. In‐utero detection of type‐ II glycogenosis (Pompe's disease). Lancet 1969; ii: 1277.

133 133. Nadler HL, Bigley RH, Hug G. Prenatal detection of Pompe's disease. Lancet 1970; ii:369.

134 134. Sutcliffe RG, Brock DJ, Robertson JG, et al. Enzymes in amniotic fluid: a study of specific activity patterns during pregnancy. J Obstet Gynaecol Br Commonw 1972; 79:895.

135 135. Butterworth J, Sutherland GR, Bain AD, et al. Lysosomal enzymes in amniotic fluid. Clin Chim Acta 1972; 39:275.

136 136. Lowden JA, Cutz E, Conen PE, et al. Prenatal diagnosis of G M1‐gangliosidosis. N Engl J Med 1973; 288:225.

137 137. Gomez‐Ospina N. Arylsulfatase A deficiency. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews. http://www.ncbi.nlm.nih.gov/pubmed/20301309 (accessed July 7, 2020).

138 138. Huijing F, Warren RJ, McLeod AG. Elevated activity of lysosomal enzymes in amniotic fluid of a fetus with mucolipidosis II (I‐cell disease). Clin Chim Acta 1973; 44:453.

139 139. Poenaru L, Mezard C, Akli S, et al. Prenatal diagnosis of mucolipidosis type II on first‐trimester amniotic fluid. Prenat Diagn 1990; 10:231.

140 140. Friedland J, Perle G, Saifer A, et al. Screening for Tay‐Sachs disease in utero using amniotic fluid. Proc Soc Exp Biol Med 1971; 136:1297.

141 141. O'Brien JS, Okada S, Fillerup DL, et al. Tay‐Sachs disease: prenatal diagnosis. Science 1971; 172:61.

142 142. Desnick RJ, Krivit W, Sharp HL. In utero diagnosis of Sandhoff's disease. Biochem Biophys Res Commun 1973; 51:20.

143 143. Potier M, Boire G, Dallaire L, et al. N‐Acetyl‐betahexosaminidase isoenzymes of amniotic fluid and maternal serum. Their relevance to prenatal diagnosis of the GM2 gangliosidoses. Clin Chim Acta 1977; 76:309.

144 144. Guetta E, Peleg L. Rapid detection of fetal Mendelian disorders: Tay‐Sachs disease. Methods Mol Biol 2008; 444:147.

145 145. Dallaire L, Gagnon M, Kinch RA. Fetal amino acid metabolism. Clin Res 1971; 19:766.

146 146. Jauniaux E, Gulbis B, Gerloo E. Free amino acids in human fetal liver and fluids at 12–17 weeks of gestation. Hum Reprod 1999; 14:1638.

147 147. Wenstrom KD, Johanning GL, Owen J, et al. Role of amniotic fluid homocysteine level and of fetal 5,10‐methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. Am J Med Genet 2000; 90:12.

148 148. Jauniaux E, Sherwood RA, Jurkovic D, et al. Amino acid concentrations in human embryological fluids. Hum Reprod 1994; 9:1175.

149 149. Jauniaux E, Gulbis B, Gerlo E, et al. Free amino acid distribution inside the first trimester human gestational sac. Early Hum Dev 1998; 51:159.

150 150. Mesavage WC, Suchy SF, Weiner DL, et al. Amino acids in amniotic fluid in the second trimester of gestation. Pediatr Res 1985; 19:1021.

151 151. Dallaire L, Potier M, Melancon SB, et al. Feto‐maternal amino acid metabolism. J Obstet Gynaecol Br Commonw 1974; 81:761.

152 152. Kamoun P, Parvy P, Pham Dinh D, et al. Citrulline in amniotic fluid and the prenatal diagnosis of citrullinemia. Prenat Diagn 1983; 3:53.

153 153. Chadefaux‐Vekemans B, Rabier D, Chabli A, et al. Improving the prenatal diagnosis of citrullinemia using citrulline/ornithine+arginine ratio in amniotic fluid. Prenat Diagn 2002; 22:456.

154 154. Kleijer WJ, Blom W, Huijmans JG, et al. Prenatal diagnosis of citrullinemia: elevated levels of citrulline in the amniotic fluid in the three affected pregnancies. Prenat Diagn 1984; 4:113.

155 155. Kleijer WJ, Garritsen VH, van der Sterre ML, et al. Prenatal diagnosis of citrullinemia and argininosuccinic aciduria: evidence for a transmission ratio distortion in citrullinemia. Prenat Diagn 2006; 26:242.

156 156. Northrup H, Beaudet AL, O'Brien WE. Prenatal diagnosis of citrullinaemia: review of a 10‐year experience including recent use of DNA analysis. Prenat Diagn 1990; 10:771.

157 157. Pettit BR, King GS, Blau K. The analysis of hexitols in biological fluid by selected ion monitoring. Biomed Mass Spectrom 1980; 7:309.

158 158. Elsas LJ, Lai K, Saunders CJ, et al. Functional analysis of the human galactose‐1‐phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 2001; 72:297.

159 159. Coude M, Chadefaux B, Rabier D, et al. Early amniocentesis and amniotic fluid organic acid levels in the prenatal diagnosis of organic acidemias. Clin Chim Acta 1990; 187:329.

160 160. Jakobs C, Ten Brink HJ, Stellaard F. Prenatal diagnosis of inherited metabolic disorders by quantitation of characteristic metabolites in amniotic fluid: facts and future. Prenat Diagn 1990; 10:265.

161 161. Lindblad B, Lindstedt S, Steen G. On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci U S A 1977; 74:4641.

162 162. Gagne R, Lescault A, Grenier A, et al. Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid. Prenat Diagn 1982; 2:185.

163 163. Poudrier J, Lettre F, St‐Louis M, et al. Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid. Prenat Diagn 1999; 19:61.

164 164. Maydan G, Andresen BS, Madsen PP, et al. TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping. J Inherit Metab Dis 2006; 29:620.

165 165. Antonowicz I, Chang SK, Grand RJ. Development and distribution of lysosomal enzymes and disaccharidases in human fetal intestine. Gastroenterology 1974; 67:51.

166 166. Morin PR, Potier M, Dallaire L, et al. Prenatal detection of the autosomal recessive type of polycystic kidney disease by trehalase assay in amniotic fluid. Prenat Diagn 1981; 1:75.

167 167. Morin PR, Potier M, Dallaire L, et al. Prenatal detection of intestinal obstruction: deficient amniotic fluid disaccharidases in affected fetuses. Clin Genet 1980; 18:217.

168 168. Claass AH, van Diggelen OP, Hauri HP, et al. Characteristics of maltase activity in amniotic fluid. Clin Chim Acta 1985; 145:275.

169 169. Potier M, Morin PR, Melancon SB, et al. Differential stabilities of fetal intestinal disaccharidases determine their relative amounts released into amniotic fluid. Biol Neonate 1984; 45:257.

170 170. Potier M, Cousineau J, Michaud L, et al. Fetal intestinal microvilli in human amniotic fluid. Prenat Diagn 1986; 6:429.

171 171. Jalanko H, Rapola J, Lehtonen E. Particulate fraction in amniotic fluid at second trimester. J Clin Pathol 1985; 38:1065.

172 172. Morin PR, Melancon SB, Dallaire L, et al. Prenatal detection of intestinal obstructions, aneuploidy syndromes, and cystic fibrosis by microvillar enzyme assays (disaccharidases, alkaline phosphatase, and glutamyltransferase) in amniotic fluid. Am J Med Genet 1987; 26:405.

173 173. Morin PR, Potier M, Dallaire L, et al. Prenatal detection of the congenital nephrotic syndrome (Finnish type) by trehalase assay in amniotic fluid. Prenat Diagn 1984; 4:257.

174 174. Poenaru L, Vinet MC, Dreyfus JC. Human amniotic fluid alpha‐glucosidase. Clin Chim Acta 1981; 117:53.

175 175. Elsliger MA, Dallaire L, Potier M. Fetal intestinal and renal origins of trehalase activity in human amniotic fluid. Clin Chim Acta 1993; 216:91.

176 176. Dallaire L, Perreault G. Hereditary multiple intestinal atresia. Birth Defects Orig Artic Ser 1974; 10:259.

177 177. Garel C, Dreux S, Philippe‐Chomette P, et al. Contribution of fetal magnetic resonance imaging and amniotic fluid digestive enzyme assays to the evaluation of gastrointestinal tract abnormalities. Ultrasound Obstet Gynecol 2006; 28:282.

178 178. Muller F, Dreux S, Vaast P, et al. Prenatal diagnosis of megacystis‐microcolon‐intestinal hypoperistalsis syndrome: contribution of amniotic fluid digestive enzyme assay and fetal urinalysis. Prenat Diagn 2005; 25:203.

179 179. Machado L, Matias A, Rodrigues M, et al. Fetal megacystis as a prenatal challenge: megacystis‐microcolonintestinal hypoperistalsis syndrome in a male fetus. Ultrasound Obstet Gynecol 2013; 41:345.

180 180. Talabani H, Dreux S, Luton D, et al. Fetal anal incontinence evaluated by amniotic fluid digestive enzyme assay in myelomeningocele spina bifida. Pediatr Res 2005; 58:766.

181 181. Potier M, Melancon SB, Dallaire L. Fetal intestinal disaccharidases in human amniotic fluid. Biomedicine 1976; 25:167.

182 182. Arey LB. Developmental anatomy: a textbook and laboratory manual of embryology, 7th edn. Philadelphia: WB Saunders, 1965.

183 183. Gitlin D, Kumate J, Morales C, et al. The turnover of amniotic fluid protein in the human conceptus. Am J Obstet Gynecol 1972; 113:632.

184 184. Mulivor RA, Mennuti MT, Harris H. Origin of the alkaline phosphatases in amniotic fluid. Am J Obstet Gynecol 1979; 135:77.

185 185. Pocknee RC, Abramovich DR. Origin and levels of trypsin in amniotic fluid throughout pregnancy. Br J Obstet Gynaecol 1982; 89:142.

186 186. van Diggelen OP, Janse HC, Kleijer WJ. Disaccharidases in amniotic fluid as possible prenatal marker for cystic fibrosis. Lancet 1983; i:817.

187 187. Jarmas AL, Weaver DD, Padilla LM, et al. Hirschsprung disease: etiologic implications of unsuccessful prenatal diagnosis. Am J Med Genet 1983; 16:163.

188 188. Carbarns NJ, Gosden C, Brock DJ. Microvillar peptidase activity in amniotic fluid: possible use in the prenatal diagnosis of cystic fibrosis. Lancet 1983; i:329.

189 189. Brock DJ. Amniotic fluid alkaline phosphatase isoenzymes in early prenatal diagnosis of cystic fibrosis. Lancet 1983; ii:941.

190 190. Szabo M, Munnich A, Teichmann F, et al. Discriminant analysis for assessing the value of amniotic fluid microvillar enzymes in the prenatal diagnosis of cystic fibrosis. Prenat Diagn 1990; 10:761.

191 191. Morin PR, Potier M, LaSalle R, et al. Amniotic‐fluid disaccharidases in the prenatal detection of cystic fibrosis. Lancet 1983; ii:621.

192 192. Janlanko H, Aula P. Decrease in gamma‐glutamyl transpeptidase activity in early amniotic fluid in fetal trisomy 18 syndrome. Br Med J 1982; 284:1593.

193 193. Jalanko H. Developmental changes in gamma‐glutamyl transpeptidase in human amniotic fluid. Oncodev Biol Med 1983; 4:253.

194 194. Moniz C, Nicolaides KH, Keys D, et al. Gammaglutamyl transferase activity in fetal serum, maternal serum, and amniotic fluid during gestation. J Clin Pathol 1984; 37:700.

195 195. Brock DJ, Bedgood D, Hayward C, et al. Amniotic fluid microvillar enzyme activities in the early detection of fetal abnormalities. Prenat Diagn 1984; 4:261.

196 196. Davidson GP, Cutz E, Hamilton JR, et al. Familial enteropathy: a syndrome of protracted diarrhea from birth, failure to thrive, and hypoplastic villus atrophy. Gastroenterology 1978; 75:783.

197 197. Abramsky O, Brenner T, Lisak RP, et al. Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor. Lancet 1979; ii:1333.

198 198. Brown CL, Colden KA, Hume RF, et al. Faint and positive amniotic fluid acetylcholinesterase with a normal sonogram. Am J Obstet Gynecol 1996; 175:1000.

199 199. Symonds EM, Williams SS, Cellier KM. Maternal and fetal influences on the acid‐base balance of human amniotic fluid. Obstet Gynecol 1971; 37:742.

200 200. Jauniaux E, Watson A, Burton G. Evaluation of respiratory gases and acid‐base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks' gestation. Am J Obstet Gynecol 2001; 184:998.

201 201. Vrachnis N, Malamitsi‐Puchner A, Samoli E, et al. Elevated mid‐trimester amniotic fluid ADAM‐8 concentrations as a potential risk factor for preterm delivery. J Soc Gynecol Investig 2006; 13:186.

202 202. Yamashiro C, Kanenishi K, Akiyama M, et al. Adrenomedullin concentrations in early 2nd‐trimester amniotic fluid: relation to preterm delivery and fetal growth at birth. Gynecol Obstet Invest 2002; 54:99.

203 203. Gulbis B, Jauniaux E, Cotton F, et al. Protein and enzyme patterns in the fluid cavities of the first trimester gestational sac: relevance to the absorptive role of secondary yolk sac. Mol Hum Reprod 1998; 4:857.

204 204. Jalanko H, Heikinheimo M, Ryynanen M, et al. Alkaline phosphatase activity in amniotic fluid in pregnancies with fetal disorders. Prenat Diagn 1983; 3: 303.

205 205. Evans HE, Glass L, Mandl I. Alpha1‐antitrypsin concentration in amniotic fluid. Biol Neonate 1975; 27:232.

206 206. Kleinbauer D, Klink F, Wagner T, et al. Blutgerinnung und Fibrinolyse Faktor‐Aktivitäten in der Amnionflüssigkeit. [Blood coagulation and fibrinolytic factor activities in the amniotic fluid]. Geburtshilfe Frauenheilkd 1988; 48:397.

207 207. Chadefaux B, Ceballos I, Rabier D, et al. Prenatal diagnosis of argininosuccinic aciduria by assay of argininosuccinate in amniotic fluid at the 12th week of gestation. Am J Med Genet 1990; 35:594.

208 208. Fernandez de Castro A, Usategui‐Gomez M, Spellacy WN. Amniotic fluid amylase. Am J Obstet Gynecol 1973; 116:931.

209 209. Dawood MY. Hormones in amniotic fluid. Am J Obstet Gynecol 1977; 128:576.

210 210. Madazli R, Atis A, Uzun H, et al. Mid‐trimester amniotic fluid angiogenin, lactate dehydrogenase and fibronectin in the prediction of preterm delivery. Eur J Obstet Gynecol Reprod Biol 2003; 106:160.

211 211. Cohen SB, Goldenberg M, Rabinovici J, et al. Anticardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti‐phospholipid syndrome. Hum Reprod 2000; 15:1170.

212 212. Pacsa AS. Impairment of immunity during pregnancy and antiviral effect of amniotic fluid. Lancet 1977; 1:330.

213 213. Fainaru M, Deckelbaum R, Golbus MS. Apolipoproteins in human fetal blood and amniotic fluid in midtrimester pregnancy. Prenat Diagn 1981; 1:125.

214 214. Ruelland A, Mention JE, Perrot Y, et al. Evolution du taux de l'apolipoproteine A dans le liquide amniotique au cours de la grossesse normale et pathologique [The levels of apolipoprotein A in liquor in normal and pathological pregnancies (author's transl.)]. J Gynecol Obstet Biol Reprod (Paris) 1982; 11:241.

215 215. Chadefaux‐Vekemans B, Rabier D, Cadoudal N, et al. Prenatal diagnosis of some metabolic diseases using early amniotic fluid samples: report of a 15 years, experience. Prenat Diagn 2006; 26:814.

216 216. Borresen AL, van der Hagen CB. Metachromatic leukodystrophy. II. Direct determination of arylsulphatase A activity in amniotic fluid. Clin Genet 1973; 4:442.

217 217. Di Lieto A, Pollio F, Catalano D, et al. Atrial natriuretic factor in amniotic fluid and in maternal venous blood of pregnancies with fetal cardiac malformations and chromosomal abnormalities. J Matern Fetal Neonatal Med 2002; 11:183.

218 218. Lewis JF, Johnson P, Miller P. Evaluation of amniotic fluid for aerobic and anaerobic bacteria. Am J Clin Pathol 1976; 65:58.

219 219. Prevedourakis C, Koumentakou E, Zolotas J, et al. E. coli growth inhibition by amniotic fluid. Acta Obstet Gynecol Scand 1976; 55:245.

220 220. Ford LC, DeLange RJ, Lebherz TB. Identification of a bactericidal factor (B‐lysin) in amniotic fluid at 14 and 40 weeks' gestation. Am J Obstet Gynecol 1977; 127:788.

221 221. Kofinas GD, Kofinas AD, Pyrgerou M, et al. Amniotic fluid beta‐endorphin levels and labor. Obstet Gynecol 1987; 69:945.

222 222. Smith AL, Scanlon J. Amnionic fluid d(2)‐betahydroxybutyrate and the dysmature newborn infant. Am J Obstet Gynecol 1973; 115:569.

223 223. Gulbis B, Gervy C, Jauniaux E. Amniotic fluid biochemistry in second‐trimester trisomic pregnancies: relationships to fetal organ maturation and dysfunction. Early Hum Dev 1998; 52:211.

224 224. Perlman M. Golden liquor amnii. Lancet 1973; i:556.

225 225. Harper P, Bias WB, Hutchinson JR, et al. ABH secretor status of the fetus: a genetic marker identifiable by amniocentesis. J Med Genet 1971; 8:438.

226 226. Arcilla MB, Sturgeon P. Lewis and ABH substances in amniotic fluid obtained by amniocentesis. Pediatr Res 1972; 6:853.

227 227. Jones MI, Spragg SP, Webb T. Detection of proteins in human amniotic fluid using two‐dimensional gel electrophoresis. Biol Neonate 1981; 39:171.

228 228. Dawson EB, Evans DR, Nosovitch J. Third‐trimester amniotic fluid metal levels associated with preeclampsia. Arch Environ Health 1999; 54:412.

229 229. Auger P, Marquis G, Dallaire L, et al. Stunted growth Candida albicans in human amniotic fluid in vitro. J Lab Clin Med 1980; 95:272.

230 230. Bussière L, Dumont J, Hubert J. Direct determination of calcium, copper, iron, magnesium, manganese and zinc in amniotic fluid samples using inductively coupled plasma‐atomic emission spectrometry. Anal Chim Acta 1989; 224:73.

231 231. Buhimschi IA, Zambrano E, Pettker CM, et al. Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis. Obstet Gynecol 2008; 111:403.

232 232. Tayyar M, Tutus A. The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA125, CA19.9, CA15.3, and CEA. Int J Fertil Womens Med 1999; 44:256.

233 233. Hahn P, Skala JP, Seccombe DW, et al. Carnitine content of blood and amniotic fluid. Pediatr Res 1977; 11:878.

234 234. Divers WA, Jr., Wilkes MM, Babaknia A, et al. An increase in catecholamines and metabolites in the amniotic fluid compartment from middle to late gestation. Am J Obstet Gynecol 1981; 139:483.

235 235. Holst RM, Laurini R, Jacobsson B, et al. Expression of cytokines and chemokines in cervical and amniotic fluid: relationship to histological chorioamnionitis. J Matern Fetal Neonatal Med 2007; 20:885.

236 236. Anteby SO, Zukerman H, Gedelia I, et al. Citric acid in amniotic fluid. J Obstet Gynaecol Br Commonw 1973; 80:27.

237 237. Tarim E, Bagis T, Kilicdag EB, et al. Are amniotic fluid C‐reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery? J Perinat Med 2005; 33:524.

238 238. Margarit L, Griffiths AN, Tsapanos V, et al. Amniotic fluid endothelin levels and the incidence of premature rupture of membranes. Int J Gynaecol Obstet 2006; 93:18.

239 239. Knepper MA, Pisitkun T. Exosomes in urine: who would have thought? Kidney Int 2007; 72:1043.

240 240. Cassady G, Hinkley C, Bailey P, et al. Amniotic fluid creatinine in pregnancies complicated by diabetes. Am J Obstet Gynecol 1975; 122:13.

241 241. Mussap M, Fanos V, Pizzini C, et al. Predictive value of amniotic fluid cystatin C levels for the early identification of fetuses with obstructive uropathies. BJOG 2002; 109:778.

242 242. Kristensen K, Larsson I, Hansson SR. Increased cystatin C expression in the pre‐eclamptic placenta. Mol Hum Reprod 2007; 13:189.

243 243. Oboh AE, Orsi NM, Campbell J. Amniotic fluid cytokine profile in association with fetal hyperechogenic bowel. Eur J Obstet Gynecol Reprod Biol 2006; 128:86.

244 244. Davis LE, Tweed GV, Chin TD, et al. Interuterine diagnosis of cytomegalovirus infection: viral recovery from amniocentesis fluid. Am J Obstet Gynecol 1971; 109:1217.

245 245. Halperin R, Halpern D, Hadas E, et al. Intrauterine levels of human decidua‐associated protein (hDP) 200 in normal pregnancy and missed abortion. Gynecol Obstet Invest 1998; 46:150.

246 246. Espinoza J, Chaiworapongsa T, Romero R, et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability‐increasing protein in patients with microbial invasion of the amniotic cavity, intra‐amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003; 13:2.

247 247. Firgaira FA, Cotton RG, Danks DM, et al. Prenatal determination of dihydropteridine reductase in a normal fetus at risk for malignant hyperphenylalaninemia. Prenat Diagn 1983; 3:7.

248 248. Adama van Scheltema PN, In't Anker PS, Vereecken A, et al. Biochemical composition of amniotic fluid in pregnancies complicated with twin–twin transfusion syndrome. Fetal Diagn Ther 2005; 20:186.

249 249. Keller S, Rupp C, Stoeck A, et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int 2007; 72:1095.

250 250. Sciarra JJ, Tagatz GE, Notation AD, et al. Estriol and estetrol in amniotic fluid. Am J Obstet Gynecol 1974; 118:626.

251 251. Ramsey PS, Andrews WW, Goldenberg RL, et al. Elevated amniotic fluid ferritin levels are associated with inflammation‐related pregnancy loss following mid‐trimester amniocentesis. J Matern Fetal Neonatal Med 2002; 11:302.

252 252. Sakura M, Nakabayashi M, Takeda Y, et al. Elevated fetal fibronectin in midtrimester amniotic fluid is involved with the onset of preeclampsia. J Obstet Gynaecol Res 1998; 24:73.

253 253. Yoneda S, Sakai M, Sasaki Y, et al. Interleukin‐8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes. J Obstet Gynaecol Res 2007; 33:38.

254 254. Clements JA, Reyes FI, Winter JS, et al. Studies on human sexual development. III. Fetal pituitary and serum, and amniotic fluid concentrations of LH, CG, and FSH. J Clin Endocrinol Metab 1976; 42:9.

255 255. Shimoya K, Zhang Q, Tenma K, et al. Fractalkine (FRK) levels in amniotic fluid and its production during pregnancy. Mol Hum Reprod 2003; 9:97.

256 256. Orczyk‐Pawilowicz M, Florianski J, Zalewski J, et al. Relative amounts of sialic acid and fucose of amniotic fluid glycoconjugates in relation to pregnancy age. Glycoconj J 2005; 22:433.

257 257. Kvittingen EA, Halvorsen S, Jellum E. Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia. Pediatr Res 1983; 17:541.

258 258. Macek M, Anneren G, Gustavson KH, et al. Gammaglutamyl transferase activity in the amniotic fluid of fetuses with chromosomal aberrations and inborn errors of metabolism. Clin Genet 1987; 32:403.

259 259. Chen AB, Mosesson MW, Solish GI. Identification of the cold‐insoluble globulin of plasma in amniotic fluid. Am J Obstet Gynecol 1976; 125:958.

260 260. Newman R, Tutera G. The glucose–insulin ratio in amniotic fluid. Obstet Gynecol 1976; 47:599.

261 261. Papp Z, Ember I, Juhasz E, et al. Acid‐soluble glycoproteins in amniotic fluid and cystic fibrosis of the foetus. Clin Genet 1977; 11:431.

262 262. Hakala‐Ala‐Pietila TH, Koistinen RA, Salonen RK, et al. Elevated second‐trimester amniotic fluid concentration of insulin‐like growth factor binding protein‐1 in fetal growth retardation. Am J Obstet Gynecol 1993; 169:35.

263 263. Appelbaum PC, Shulman G, Chambers NL, et al. Studies on the growth‐inhibiting property of amniotic fluids from two United States population groups. Am J Obstet Gynecol 1980; 137:579.

264 264. Jean‐Pierre C, Perni SC, Bongiovanni AM, et al. Extracellular 70‐kd heat shock protein in mid‐trimester amniotic fluid and its effect on cytokine production by ex vivo‐cultured amniotic fluid cells. Am J Obstet Gynecol 2006; 194:694.

265 265. Gelber SE, Bongiovanni AM, Jean‐Pierre C, et al. Witkin SS. Antibodies to the 70 kDa heat shock protein in midtrimester amniotic fluid and intraamniotic immunity. Am J Obstet Gynecol 2007; 197:278 e1.

266 266. Gitlin D, Biasucci A. Development of gamma G, gamma A, gamma M, beta IC‐beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1‐antitrypsin, orosomucoid, beta‐lipoprotein, alpha 2‐macroglobulin, and prealbumin in the human conceptus. J Clin Invest 1969; 48:1433.

267 267. Rebmann V, LeMaoult J, Rouas‐Freiss N, et al. Quantification and identification of soluble HLA‐G isoforms. Tissue Antigens 2007; 69 Suppl 1:143.

268 268. Emmer PM, Steegers EA, van Lierop MJ, et al. Amniotic fluid soluble human leukocyte antigen G is markedly decreased in offspring with neural tube defects. Early Hum Dev 2002; 66:101.

269 269. Deh ME, Klouda PT, Levine M, et al. Detection, isolation and characterization of cell free HLA A and B antigens from human amniotic fluid. Tissue Antigens 1982; 20:260.

270 270. Nicholls T, Hahnel R, Wilkinson S, et al. Identification of 2‐hydroxybutyric acid in human amniotic fluid. Clin Chim Acta 1976; 69:127.

271 271. Emery AE, Brock DJ, Burt D, et al. Amniotic fluid composition in malformations of the fetal central nervous system. J Obstet Gynaecol Br Commonw 1974; 81:512.

272 272. GadowEC, Floriani FA, Florin A. IgG levels in amniotic fluid. Am J Obstet Gynecol 1974; 119:849.

273 273. Wilfert CM, Gradoville ML. In vitro viral studies of cells grown from human amniotic fluid samples. Am J Obstet Gynecol 1974; 118:1073.

274 274. Thirunavukarasu PP, Lambert‐Messerlian G, Robertson DM, et al. Molecular weight forms of inhibin A, inhibin B and pro‐alpha C in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies. Prenat Diagn 2002; 22:1086.

275 275. Verhaeghe J, Coopmans W, van Herck E, et al. IGF‐I, IGF‐II, IGF binding protein 1, and C‐peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth. Pediatr Res 1999; 46:101.

276 276. Weiss PA, Purstner P, Winter R, et al. Insulin levels in amniotic fluid of normal and abnormal pregnancies. Obstet Gynecol 1984; 63:371.

277 277. Baviera G, D'Anna R, Corrado F, et al. ICAM‐1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR. J Reprod Med 2002; 47:191.

278 278. Malamitsi‐Puchner A, Vrachnis N, Samoli E, et al. Elevated second trimester amniotic fluid interferon gamma‐inducible T‐cell alpha chemoattractant concentrations as a possible predictor of preterm birth. J Soc Gynecol Investig 2006; 13:25.

279 279. Menon R, Camargo MC, Thorsen P, et al. Amniotic fluid interleukin‐6 increase is an indicator of spontaneous preterm birth in white but not black Americans. Am J Obstet Gynecol 2008; 198:77 e1.

280 280. Rayburn WF, Robinson A, Braverman LE, et al. Iodide concentrations in matched maternal serum, cord serum, and amniotic fluid from preterm and term human pregnancies. Reprod Toxicol 2008; 25:129.

281 281. Garcia‐Fuentes E, Gallo M, Garcia L, et al. Amniotic fluid iodine concentrations do not vary in pregnant women with varying iodine intake. Br J Nutr 2008; 99:1178.

282 282. Maymon R, Jauniaux E, Rodeck C, et al. Comparison of placental isoferritin levels in maternal serum and coelomic and amniotic fluids during first trimester human gestation. Hum Reprod 1998; 13:1044.

283 283. Wolf RO, Taussig LM. Human amniotic fluid isoamylases. Functional development of fetal pancreas and salivary glands. Obstet Gynecol 1973; 41:337.

284 284. Perrone S, Longini M, Bellieni CV, et al. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007; 40:177.

285 285. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53:1423.

286 286. Kidokoro K, Furuhashi M, Kuno N, et al. Amniotic fluid neutrophil elastase and lactate dehydrogenase: association with histologic chorioamnionitis. Acta Obstet Gynecol Scand 2006; 85:669.

287 287. Otsuki K, Yoda A, Saito H, et al. Amniotic fluid lactoferrin in intrauterine infection. Placenta 1999; 20:175.

288 288. Stoll C, Dott B, Maier EA, et al. Oligo‐éléments du liquide amniotique des foetus normaux, hypotrophes et trisomiques 21 [Oligo‐elements of the amniotic fluid from normal, hypotrophic and trisomy 21 fetuses]. Rev Fr Gynecol Obstet 1990; 85:45.

289 289. Larsen B, Galask RP, Snyder IS. Muramidase and peroxidase activity of human amniotic fluid. Obstet Gynecol 1974; 44:219.

290 290. Hayashi M, Zhu K, Sagesaka T, et al. Elevation of amniotic fluid macrophage colony‐stimulating factor in normotensive pregnancies that delivered small‐for‐gestational‐age infants. Am J Reprod Immunol 2007; 57:488.

291 291. Fujikura T, Klionsky B. The significance of meconium staining. Am J Obstet Gynecol 1975; 121:45.

292 292. Kim KW, Romero R, Park HS, et al. A rapid matrix metalloproteinase‐8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2007; 197:292 e1.

293 293. Fasching G, Haeusler M, Mayr J, et al. Can levels of interleukins and matrix metalloproteinases in the amniotic fluid predict postnatal bowel function in fetuses with gastroschisis? J Pediatr Surg 2005; 40: 1887.

294 294. Nishijima K, Shukunami K, Tsukahara H, et al. Micelles of pulmonary surfactant in human amniotic fluid at term. Pediatr Res 2006; 60:196.

295 295. Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983; 10:294.

296 296. Kastner B, Schenk H, Weise W, et al. Der Neuraminsaure/Protein‐Quotient im Fruchtwasser: Indikator fur die fetale Reife [The neuraminic acid/protein quotient in amniotic fluid: indicator for fetal maturity]. Z Med Lab Diagn 1990; 31:77.

297 297. Marx CE, Vance BJ, Jarskog LF, et al. Nerve growth factor, brain‐derived neurotrophic factor, and neurotrophin‐3 levels in human amniotic fluid. Am J Obstet Gynecol 1999; 181:1225.

298 298. Elimian A, Figueroa R, Patel K, et al. Reference values of amniotic fluid neuron‐specific enolase. J Matern Fetal Med 2001; 10:155.

299 299. Daoud GA, Suzuki Y,Yamamoto T, et al. Reduced nitric oxide in amniotic fluid of patients with chorioamnionitis. Fetal Diagn Ther 2006; 21:77.

300 300. Tranquilli AL, Bezzeccheri V, Scagnoli C, et al. Amniotic levels of vascular endothelial growth factor and nitric oxide at the second trimester in Down's syndrome. J Matern Fetal Neonatal Med 2003; 13:28.

301 301. Dawson EB, Harris WA, Evans DR, et al. Amniotic fluid amino and nucleic acid in normal and neural tube defect pregnancies. A comparison. J Reprod Med 1999; 44:28.

302 302. Lu LC, Hsu CD. Elevated amniotic fluid nucleosome levels in women with intra‐amniotic infection. Obstet Gynecol 1999; 94:7.

303 303. Ruhle W, Graf von Ballestrem CL, Pult HM, et al. Korrelation des Cotininspiegels in Fruchtwasser, Nabelarterienblut und mutterlichem Blut [Correlation of cotinine level in amniotic fluid, umbilical artery blood and maternal blood]. Geburtshilfe Frauenheilkd 1995; 55:156.

304 304. Ramsay SL, Maire I, Bindloss C, et al. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases. Mol Genet Metab 2004; 83:231.

305 305. Nicholls TM, Hahnel R, Wilkinson SP. Organic acids in amniotic fluid. Clin Chim Acta 1978; 84:11.

306 306. Baggot PJ, Eliseo AJ, DeNicola NG, et al. Organic acid concentrations in amniotic fluid found in normal and Down syndrome pregnancies. Fetal Diagn Ther 2008; 23:245.

307 307. Mattison DR. Amniotic fluid osmolality. Obstet Gynecol 1970; 36:420.

308 308. Wandzilak TR, Hanson FW, Williams HE. The quantitation of oxalate in amniotic fluid by ion chromatography. Clin Chim Acta 1989; 185:131.

309 309. Johnell HE, Nilsson BA. Oxygen tension, acid‐base status and electrolytes in human amniotic fluid. Acta Obstet Gynecol Scand 1971; 50:183.

310 310. Seppala M, Aho I, Tissari A, et al. Radioimmunoassay of oxytocin in amniotic fluid, fetal urine, and meconium during late pregnancy and delivery. Am J Obstet Gynecol 1972; 114:788.

311 311. Westergaard JG, Chemnitz J, Teisner B, et al. Pregnancy‐associated plasma protein A: a possible marker in the classification and prenatal diagnosis of Cornelia de Lange syndrome. Prenat Diagn 1983; 3:225.

312 312. Schlievert P, Johnson W, Galask RP. Bacterial growth inhibition by amniotic fluid. V. Phosphate‐to‐zinc ratio as a predictor of bacterial growth‐inhibitory activity. Am J Obstet Gynecol 1976; 125:899.

313 313. Mihailovic M, Cvetkovic M, Ljubic A, et al. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid. Biol Trace Elem Res 2000; 73:47.

314 314. Condroelli S, Cosmi EV, Scarpelli EM. Extrapulmonary source of amniotic fluid phospholipids. Am J Obstet Gynecol 1974; 118:842.

315 315. Moon TC, Lee JH, Lee SH, et al. Detection and characterization of a type IIA secretory phospholipase A2 inhibitory protein in human amniotic fluid. Biol Pharm Bull 2000; 23:1163.

316 316. Foster WG, Chan S, Platt L, Hughes CL, Jr. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 2002; 129:199.

317 317. Makrydimas G, Sotiriadis A, Savvidou MD, et al. Physiological distribution of placental growth factor and soluble Flt‐1 in early pregnancy. Prenat Diagn 2008; 28:175.

318 318. Vesce F, Scapoli C, Giovannini G, et al. Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies. Obstet Gynecol 2001; 97:404.

319 319. Verkleij‐Hagoort AC, Ursem NT, Hop WC, et al. Complex congenital malformations and the impact of the plasminogen activator system and beta‐hCG in amniotic fluid. Eur J Obstet Gynecol Reprod Biol 2007; 135:47.

320 320. Prado VF, Reis DD, Pena SD. Biochemical and immunochemical identification of the fetal polypeptides of human amniotic fluid during the second trimester of pregnancy. Braz J Med Biol Res 1990; 23:121.

321 321. Phillips LL, Davidson EC, Jr. Procoagulant properties of amniotic fluid. Am J Obstet Gynecol 1972; 113: 911.

322 322. Kauppila S, Tekay A, Risteli L, et al. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta. Eur J Clin Invest 1998; 28:831.

323 323. Ben‐Jonathan N, Munsick RA. Dopamine and prolactin in human pregnancy. J Clin Endocrinol Metab 1980; 51:1019.

324 324. Singh EJ, Zuspan FP. Content of amniotic fluid prostaglandins in normal, diabetic, and drug‐abuse human pregnancy. Am J Obstet Gynecol 1974; 118: 358.

325 325. Graca G, Duarte IF, Goodfellow BJ, et al. Potential of NMR spectroscopy for the study of human amniotic fluid. Anal Chem 2007; 79:8367.

326 326. Kaufman S. Protein‐bound iodine (pbi) in human amniotic fluid. J Pediatr 1966; 68:990.

327 327. Uszynski M, Zekanowska E, Kotzbach M, et al. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study. J Perinat Med 2006; 34:289.

328 328. Chi L, Wolff JJ, Laremore TN, et al. Structural analysis of bikunin glycosaminoglycan. J Am Chem Soc 2008; 130:2617.

329 329. Porre S, Heinonen S, Mantyjarvi R, et al. Psoriasin, a calcium‐binding protein with chemotactic properties is present in the third trimester amniotic fluid. Mol Hum Reprod 2005; 11:87.

330 330. Franks RC, Hayashi RH. Maternal and fetal renin activity and renin and big renin concentrations in second‐trimester pregnancy. Am J Obstet Gynecol 1979; 134:20.

331 331. Cederqvist LL, Zervoudakis IA, Ewool LC, et al. Prenatal diagnosis of congenital rubella. Br Med J 1977; 1:615.

332 332. Teichler‐Zallen D, Doherty RA. Amniotic fluid secretor typing: validation for use in prenatal prediction of myotonic dystrophy. Clin Genet 1980; 18:257.

333 333. Aula N, Aula P. Prenatal diagnosis of free sialic acid storage disorders (SASD). Prenat Diagn 2006; 26:655.

334 334. Cox LW, Chalmers TA. The transfer of sodium to the amniotic fluid in normal and abnormal cases, determined by Na24 tracer methods. J Obstet Gynaecol Br Emp 1953; 60:222.

335 335. Tham A, Wetterberg L, Sara VR. Immunoreactive somatomedin B in the human foetus and in women during pregnancy. Acta Endocrinol (Copenh) 1987; 115:218.

336 336. Niswander KR. Spectrophotometric analysis of amniotic fluid in early gestation. Am J Obstet Gynecol 1970; 108:1296.

337 337. Fortunato SJ, Menon R, Lombardi SJ. Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes. Obstet Gynecol 1999; 94:435.

338 338. Frosolono MF, Roux JF. Surface‐active material in human amniotic fluid. Am J Obstet Gynecol 1978; 130: 562.

339 339. Muller‐Tyl E, Lempert J, Steinbereithner K, et al. Surface properties of the amniotic fluid in normal pregnancy. Am J Obstet Gynecol 1975; 122:295.

340 340. Belisle S, Fencl MM, Tulchinsky D. Amniotic fluid testosterone and follicle‐stimulating hormone in the determination of fetal sex. Am J Obstet Gynecol 1977; 128:514.

341 341. Tersenov OA, Mikhaleva IV, Usol'tseva VA, et al. O svertyvaiushchei aktivnosti okoloplodnykh vod [Coagulative activity of the amniotic fluid]. Akush Ginekol (Mosk) 1989: 43.

342 342. Sainio S, Javela K, Kekomaki R, et al. Thrombopoietin levels in cord blood plasma and amniotic fluid in fetuses with alloimmune thrombocytopenia and healthy controls. Br J Haematol 2000; 109:330.

343 343. Hall GS, Carr MJ, Cummings E, et al. Aluminum, barium, silicon, and strontium in amniotic fluid by emission spectrometry. Clin Chem 1983; 29:1318.

344 344. Hufner M, Grussendorf M, Lorenz U, et al. 3,3′,5′‐Triiodothyronine (reverse T3) in amniotic fluid and cord serum. Eur J Pediatr 1977; 125:213.

345 345. Stefanovic V, Loukovaara M. Amniotic fluid cardiac troponin T in pathological pregnancies with evidence of chronic fetal hypoxia. Croat Med J 2005; 46: 801.

346 346. Menon R, Thorsen P, Vogel I, et al. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)‐alpha and soluble TNF receptors in spontaneous preterm birth. Am J Obstet Gynecol 2008; 198: 533 e1.

347 347. Park CW, Park JS, Shim SS, et al. An elevated maternal plasma, but not amniotic fluid, soluble fms‐like tyrosine kinase‐1 (sFlt‐1) at the time of mid‐trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol 2005; 193:984.

348 348. Enlander D. Amniotic fluid indicators of fetal maturity. Obstet Gynecol 1972; 40:605.

349 349. Kobayashi H, Suzuki K, Sugino D, et al. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol 1999; 180:141.

350 350. Wallingford JC, Milunsky A, Underwood BA. Vitamin A and retinol‐binding protein in amniotic fluid. Am J Clin Nutr 1983; 38:377.

351 351. Gardiki‐Kouidou P, Seller MJ. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin Genet 1988; 33:441.

352 352. Weisman Y, Jaccard N, Legum C, et al. Prenatal diagnosis of vitamin D‐dependent rickets, type II: response to 1,25‐dihydroxyvitamin D in amniotic fluid cells and fetal tissues. J Clin Endocrinol Metab 1990; 71:937.

353 353. Lacourt GC, Arendt J, Cox J, et al. Microcephalic dwarfism with associated low amniotic fluid 5‐hydroxyindole‐3‐acetic acid (5HIAA). Report of a case of Cornelia de Lange syndrome. Helv Paediatr Acta 1977; 32:149.

354 354. Weiss PA, Kainer F, Haeusler M, et al. Amniotic fluid insulin levels in nondiabetic pregnant women: an update. Arch Gynecol Obstet 1998; 262:81.

355 355. Johnson MR, Abbas A, Nicolaides KH, et al. Distribution of relaxin between human maternal and fetal circulations and amniotic fluid. J Endocrinol 1992; 134:313.

356 356. Caserta D, Mantovani A, Ciardo F, et al. Heavy metals in human amniotic fluid: a pilot study. Prenat Diagn 2011; 31:792.

357 357. Caserta D, Graziano A, Lo Monte G, et al. Heavy metals and placental fetal‐maternal barrier: a mini‐review on the major concerns. Eur Rev Med Pharmacol Sci 2013; 17:2198.

358 358. Chez RA, Henkin RI, Fox R. Amniotic fluid copper and zinc concentrations in human pregnancy. Obstet Gynecol 1978; 52:125.

359 359. Nusbaum MJ, Zettner A. The content of calcium, magnesium, copper, iron, sodium, and potassium in amniotic fluid from eleven to nineteen weeks' gestation. Am J Obstet Gynecol 1973; 115:219.

360 360. Keppen LD, Pysher T, Rennert OM. Zinc deficiency acts as a co‐teratogen with alcohol in fetal alcohol syndrome. Pediatr Res 1985; 19:944.

361 361. Ward N, Bryce‐Smith DM, Minski M, et al. Multi element neutron activation analysis of amniotic fluid in relation to varying gestational membrane ruptures. In: Bratter P, Schramel P, eds. Analytical chemistry in medicine and biology. Proceedings of the 2nd International Workshops. Berlin: de Gruyter, 1983:483.

362 362. Parkinson CE, Tan JC, Gal I. Vitamin A concentration in amniotic fluid and maternal serum related to neural tube defects. Br J Obstet Gynaecol 1982; 89:935.

363 363. Parkinson CE, Tan JC, Lewis PJ, et al. Amniotic fluid zinc and copper and neural tube defects. J Obstet Gynaecol 1981; 1:207.

364 364. Tamura T, Weekes EW, Birch R, et al. Relationship between amniotic fluid and maternal blood nutrient levels. J Perinat Med 1994; 22:227.

365 365. Dawson EB, Evans DR, Van Hook JW. Amniotic fluid B12 and folate levels associated with neural tube defects. Am J Perinatol 1998; 15:511.

366 366. Dawson EB, Evans DR, Harris WA, et al. Amniotic fluid B12, calcium, and lead levels associated with neural tube defects. Am J Perinatol 1999; 16: 373.

367 367. Luglie PF, Frulio A, Campus G, et al. Dosaggio del mercurio nel liquido amniotico umano [Mercury determination in human amniotic fluid]. Minerva Stomatol 2000; 49:155.

368 368. Kozikowska I, Binkowski LJ, Szczepanska K, et al. Mercury concentrations in human placenta, umbilical cord, cord blood and amniotic fluid and their relations with body parameters of newborns. Environ Pollut 2013; 182:256.

369 369. Milnerowicz H, Zalewski J, Geneja R, et al. Poziom metali Cd i Pb we krwi oraz Zn, Cu, Cd i Pb w wodach płodowych kobiet palacych papierosy podczas ciazy powikłanej małowodziem lub przedwczesnym odpływaniem w'od płodowych [Levels of Cd, Pb in blood and Zn, Cu, Cd, Pb in amniotic fluid of tobacco smoking women during pregnancy complicated oligohydramnios or premature rupture of membranes]. Ginekol Pol 2000; 71:311.

370 370. Hodari AA, Mariona FG, Houlihan RT, et al. Creatinine transport in the maternal–fetal complex. Obstet Gynecol 1973; 41:47.

371 371. Droegemueller W, Jackson C, Makowski EL, et al. Amniotic fluid examination as an aid in the assessment of gestational age. Am J Obstet Gynecol 1969; 104: 424.

372 372. Sharma SD, Trussell RR. The value of amniotic fluid examination in the assessment of fetal maturity. J Obstet Gynaecol Br Commonw 1970; 77:215.

373 373. Muller F, Bernard MA, Benkirane A, et al. Fetal urine cystatin C as a predictor of postnatal renal function in bilateral uropathies. Clin Chem 1999; 45:2292.

374 374. Renwick JH, Lawler SD. Genetical linkage between the ABO and nail‐patella loci. Ann Hum Genet 1955; 19:312.

375 375. Bongers EM, de Wijs IJ, Marcelis C, et al. Identification of entire LMX1B gene deletions in nail patella syndrome: evidence for haploinsufficiency as the main pathogenic mechanism underlying dominant inheritance in man. Eur J Hum Genet 2008; 16:1240.

376 376. Renwick JH, Bundey SE, Ferguson‐Smith MA, Izatt MM. Confirmation of linkage of the loci for myotonic dystrophy and ABH secretion. J Med Genet 1971; 8:407.

377 377. Milunsky A, Skare JC, Milunsky JM, et al. Prenatal diagnosis of myotonic muscular dystrophy with linked deoxyribonucleic acid probes. Am J Obstet Gynecol 1991; 164:751.

378 378. Kamsteeg EJ, Kress W, Catalli C, et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 2012; 20:1203.

379 379. Durandy A, Cerf‐Bensussan N, Dumez Y, et al. Prenatal diagnosis of severe combined immunodeficiency with defective synthesis of HLA molecules. Prenat Diagn 1987; 7:27.

380 380. Dundar O, Yoruk P, Tutuncu L, et al. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction. Prenat Diagn 2008; 28:887.

381 381. Davis LE, McLaren LC, Stewart JA, et al. Immunological and microbiological studies of midtrimester amniotic fluid. Gynecol Obstet Invest 1983; 16:261.

382 382. Boulley AM, Vial M, Bessis R, et al. Diagnostic antenatal de deux cas de maladie des inclusions cytomegaliques [Antenatal diagnosis of 2 cases of cytomegalic inclusion disease]. Arch Fr Pediatr 1984; 41:123.

383 383. Auger P, Marquis G, Dallaire L, et al. Natural occurrence of a humoral response to Candida in human amniotic fluid. Am J Obstet Gynecol 1980; 136:1075.

384 384. Emelyanova AI, Mikheeva GA, Ermakova GG. Amniotic fluid immunoglobulins at different dates of pregnancy [in Russian]. Akush Ginekol (Mosk) 1982; 7:19.

385 385. Harwick HJ, Iuppa JB, Fekety FR, Jr. Microorganisms and amniotic fluid. Obstet Gynecol 1969; 33:256.

386 386. Tafari N, Ross SM, Naeye RL, et al. Failure of bacterial growth inhibition by amniotic fluid. Am J Obstet Gynecol 1977; 128:187.

387 387. Thadepalli H, Appleman MD, Maidman JE, et al. Antimicrobial effect of amniotic fluid against anaerobic bacteria. Am J Obstet Gynecol 1977; 127:250.

388 388. Walsh H, Hildebrandt RJ, Prystowsky H. Growth inhibition factors in amniotic fluid. Am J Obstet Gynecol 1965; 93:590.

389 389. Sarkany I, Gaylarde CC. The effect of amniotic fluid on bacterial growth. Br J Dermatol 1968; 80:241.

390 390. Gusdon JP. A bactericidin for Bacillus subtilis in pregnancy. J Immunol 1962; 88:494.

391 391. Galask RP, Snyder IS. Bacterial inhibition by amniotic fluid. Am J Obstet Gynecol 1968; 102:949.

392 392. Altieri C, Maruotti G, Natale C, et al. In vitro survival of Listeria monocytogenes in human amniotic fluid. Zentralbl Hyg Umweltmed 1999; 202:377.

393 393. Bratlid D, Lindback T. Bacteriolytic activity of amniotic fluid. Obstet Gynecol 1978; 51:63.

394 394. Schlievert PS, Johnson W, Galask RP. Bacterial growth inhibition by amniotic fluid. VI. Evidence for a zinc peptide antibacterial system. Am J Obstet Gynecol 1976; 125:906.

395 395. Soto E, Espinoza J, Nien JK, et al. Human beta‐defensin‐2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2007; 20:15.

396 396. Thadepalli H, Bach VT, Davidson EC, Jr. Antimicrobial effect of amniotic fluid. Obstet Gynecol 1978; 52:198.

397 397. Kim JY, Park SC, Lee JK, et al. Novel antibacterial activity of beta(2)‐microglobulin in human amniotic fluid. PLoS One 2012; 7:e47642.

398 398. Evaldson G, Nord CE. Amniotic fluid activity against Bacteroides fragilis and group B streptococci. Med Microbiol Immunol 1981; 170:11.

399 399. Ismail MA, Salti GI, Moawad AH. Effect of amniotic fluid on bacterial recovery and growth: clinical implications. Obstet Gynecol Surv 1989; 44:571.

400 400. Martius J, Eschenbach DA. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity – a review. Arch Gynecol Obstet 1990; 247:1.

401 401. Farzin A, Boyer P, Ank B, et al. Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. AIDS Res Hum Retroviruses 2013; 29:77.

402 402. Charles D, Edwards WR. Infectious complications of cervical cerclage. Am J Obstet Gynecol 1981; 141:1065.

403 403. Lebon P, Girard S, Thepot F, et al. Embryologie générale: présence constante d'interféron de type a dans les liquides amniotiques humains. C R Hebd Seances Acad Sci Paris 1981; 293:69.

404 404. Morgan‐Capner P, Rodeck CH, Nicolaides KH, et al. Prenatal detection of rubella‐specific IgM in fetal sera. Prenat Diagn 1985; 5:21.

405 405. Ho‐Terry L, Terry GM, Londesborough P. Diagnosis of foetal rubella virus infection by polymerase chain reaction. J Gen Virol 1990; 71 (Pt 7):1607.

406 406. Bosma TJ, Corbett KM, Eckstein MB, et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995; 33:2881.

407 407. Combs CA, Gravett M, Garite TJ, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014; 210:125 e1.

408 408. Ardissone AN, de la Cruz DM, Davis‐Richardson AG, et al. Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One 2014; 9:e90784.

409 409. Pons JC, Vial P, Rozenberg F, et al. Diagnostic prenatal de la foetopathie varicelleuse au deuxi`eme trimester de la grossesse. [Prenatal diagnosis of fetal varicella in the second trimester of pregnancy]. J Gynecol Obstet Biol Reprod (Paris) 1995; 24:829.

410 410. Dufour P, de Bievre P, Vinatier D, et al. Varicella and pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 66:119.

411 411. Shukla SK, Meier PR, Mitchell PD, et al. Leptotrichia amnionii sp. nov., a novel bacterium isolated from the amniotic fluid of a woman after intrauterine fetal demise. J Clin Microbiol 2002; 40:3346.

412 412. Blanco JD, Gibbs RS, Krebs LF, et al. The association between the absence of amniotic fluid bacterial inhibitory activity and intra‐amniotic infection. Am J Obstet Gynecol 1982; 143:749.

413 413. Grose C, Weiner CP. Prenatal diagnosis of congenital cytomegalovirus infection: two decades later. Am J Obstet Gynecol 1990; 163:447.

414 414. Derouin F, Thulliez P, Candolfi E, et al. Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol Infect Dis 1988; 7:423.

415 415. Leiberman JR, Hagay ZJ, Dagan R. Intraamniotic Haemophilus influenzae infection. Arch Gynecol Obstet 1989; 244:183.

416 416. Zauli DA, de Menezes CL, de Oliveira CL. Development and padronization of three multiplex PCRs for the diagnosis of Chlamydia trachomatis, Toxoplasma gondii, herpes simplex viruses 1 and 2, and cytomegalovirus. Mol Biotechnol 2013; 54:1004.

417 417. Curtin WM, Menegus MA, Patru MM, et al. Midtrimester fetal herpes simplex‐2 diagnosis by serology, culture and quantitative polymerase chain reaction. Fetal Diagn Ther 2013; 33:133.

418 418. Czader M, Post K, Cheng L. Detection of cytomegalovirus infection by quantitative polymerase chain reaction. Methods Mol Biol 2013; 999:257.

419 419. Bourgeois‐Nicolaos N, Cordier AG, Guillet‐Caruba C, et al. Evaluation of the Cepheid Xpert GBS assay for rapid detection of group B streptococci in amniotic fluids from pregnant women with premature rupture of membranes. J Clin Microbiol 2013; 51:1305.

420 420. Bernard B, Barton L, Abate M, et al. Maternal–fetal transfer of cefazolin in the first twenty weeks of pregnancy. J Infect Dis 1977; 136:377.

421 421. Giamarellou H, Gazis J, Petrikkos G, et al. A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy. Am J Obstet Gynecol 1983; 147:914.

422 422. Allegaert K, van Mieghem T, Verbesselt R, et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol 2009; 200:170 e1.

423 423. Atkinson G, Campbell DJ, Cawood ML, et al. Steroids in human intrauterine fluids of early pregnancy. Clin Endocrinol (Oxf) 1996; 44:435.

424 424. Nakanishi T, Suzumori N, Mizuno H, et al. Elevated aldosterone in amniotic fluid and maternal blood has diagnostic potential in pregnancies complicated with a fetus of Bartter syndrome. Fetal Diagn Ther 2005; 20:481.

425 425. Mennuti MT, Wu CH, Mellman WJ, et al. Amniotic fluid testosterone and follicle stimulating hormone levels as indicators of fetal sex during mid‐pregnancy. Am J Med Genet 1977; 1:211.

426 426. Wisniewski L, Jezuita J, Bogoniowska Z, et al. Endokrynologia prenatalna. I. Kortyzol w plynie owodniowym i w surowicy krwi kobiet w 17 tygodniu ciazy [Prenatal endocrinology. II. Growth hormone in the amniotic fluid and blood serum of women in the 17th week of pregnancy]. Ginekol Pol 1983; 54:693.

427 427. Goebelsmann U, Abboud TK, Hoffman DI, et al. Beta endorphin in pregnancy. Eur J Obstet Gynecol Reprod Biol 1984; 17:77.

428 428. Teramo K, Kari MA, Eronen M, et al. High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 2004; 47:1695.

429 429. Freeman R, Lev‐Gur M, Koslowe R, et al. Maternal plasma and amniotic fluid levels of estradiol, estrone, progesterone, and prolactin in early pregnancy. Obstet Gynecol 1984; 63:507.

430 430. Sugar J, Dessy C, Alexander S, et al. Estriol‐3‐glucuronide and estriol‐16‐glucuronide in amniotic fluid during normal pregnancy. J Clin Endocrinol Metab 1980; 50:137.

431 431. Zamlynski J, Chudek J, Olejek A, et al. Galanin concentrations in maternal circulation, amniotic fluid and umbilical cord blood during term labor: relationship with maternal body mass and neonatal birth weight. Gynecol Endocrinol 2007; 23:295.

432 432. Heikinheimo M, Seppala M, Brock DJ. Pregnancy specific beta 1‐glycoprotein and human chorionic gonadotrophin levels in amniotic fluid and maternal serum in the first half of pregnancy. Oncodev Biol Med 1980; 1:71.

433 433. Dattatreyamurty B, Sheth AR, Purandare TV, et al. Gonadotrophins during second trimester of pregnancy: I. LH and hCG levels in maternal serum and amniotic fluid and their relationship to the sex of the foetus. Acta Endocrinol (Copenh) 1979; 91:692.

434 434. Buhling KJ, Monnich J, Henrich W, et al. Zusammenhang zwischen Fruchtwasserinsulin im zweiten Trimenon, mutterlicher Glukosetoleranz und fetalen Fehlbildungen [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetalmalformations]. Z Geburtshilfe Neonatol 2004; 208:226.

435 435. Tisi DK, Liu XJ, Wykes LJ, et al. Insulin‐like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr 2005; 135:1667.

436 436. Bay K, Cohen AS, Jorgensen FS, et al. Insulin‐like factor 3 levels in second‐trimester amniotic fluid. J Clin Endocrinol Metab 2008; 93:4048.

437 437. D'Anna R, Baviera G, Cannata ML, et al. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes. Gynecol Obstet Invest 2007; 64:65.

438 438. Marek S, Bock K, Hellmeyer L, et al. Herkunft und Bedeutung von Leptin und Neuropeptid Y (NPY) im Fruchtwasser zwischen der 14.‐ 18. Schwangerschaftswoche [Origin and significance of leptin and neuropeptide Y (NPY) in amniotic fluid between the 14th and 18th weeks of gestation]. Z Geburtshilfe Neonatol 2006; 210:208.

439 439. Petrucha RA, Goebelsmann U, Hung TT, et al. Amniotic fluid beta‐endorphin and beta‐lipotropin concentrations during the second and third trimesters. Am J Obstet Gynecol 1983; 146:644.

440 440. Shi‐hao Y. Prolaktin u amnijskoj tekucini i serumu u ranoj trudnoci. [Prolactin in amnionic fluid and serum of women in early pregnancy (author's transl.)]. Jugosl Ginekol Opstet 1981; 21:116.

441 441. Lee SE, Romero R, Park IS, et al. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med 2008; 21:89.

442 442. van de Beek C, Thijssen JH, Cohen‐Kettenis PT, et al. Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure? Horm Behav 2004; 46:663.

443 443. Cooper E, Anderson A, Bennett MJ, et al. Radioimmunoassay of thyroxine and 3,3′,5′‐triiodothyronine (reverse T3) in human amniotic fluid. Clin Chim Acta 1982; 118:57.

444 444. Vascotto C, Salzano AM, D'Ambrosio C, et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007; 6:160.

445 445. Wu CH, Mennuti MT, Mikhail G. Free and protein‐bound steroids in amniotic fluid of midpregnancy. Am J Obstet Gynecol 1979; 133:666.

446 446. Merger C, Blanc B, Ruf H, et al. Dosage de la testosterone, delta 4‐androstenedione et S‐DHA dans le liquide amniotique et sexe foetal [The level of testosterone, delta 4‐androstenedione, and S‐DHA in liquor and fetal sex (author's transl.)]. J Gynecol Obstet Biol Reprod (Paris) 1981; 10:567.

447 447. Carson DJ, Okuno A, Lee PA, et al. Amniotic fluid steroid levels. Fetuses with adrenal hyperplasia, 46,XXY fetuses, and normal fetuses. Am J Dis Child 1982; 136:218.

448 448. Mean F, Pescia G, Vajda D, et al. Amniotic fluid testosterone in prenatal sex determination. J Genet Hum 1981; 29:441.

449 449. Robinson JD, Judd HL, Young PE, et al. Amniotic fluid androgens and estrogens in midgestation. J Clin Endocrinol Metab 1977; 45:755.

450 450. Abramovich DR, Herriot R, Stott J. Dihydrotestosterone levels at midpregnancy and term: a comparison with testosterone concentrations. Br J Obstet Gynaecol 1983; 90:232.

451 451. Perera DM, McGarrigle HH, Lawrence DM, et al. Amniotic fluid testosterone and testosterone glucuronide levels in the determination of foetal sex. J Steroid Biochem 1987; 26:273.

452 452. Roig MD, Sabria J, Valls C, et al. The use of biochemical markers in prenatal diagnosis of intrauterine growth retardation: insulin‐like growth factor I, Leptin, and alpha‐fetoprotein. Eur J Obstet Gynecol Reprod Biol 2005; 120:27.

453 453. Anand‐Ivell R, Ivell R, Driscoll D, et al. Insulin‐like factor 3 levels in amniotic fluid of human male fetuses. Hum Reprod 2008; 23:1180.

454 454. Blankstein J, Kraiem Z, Mashiah S, et al. Effect of dexamethasone administration at midgestation on cortisol levels in amniotic fluid. Isr J Med Sci 1979; 15:945.

455 455. Friedrich E, Habedank M, Cooreman G, et al. Diagnostik der fotalen Schilddrusenfunktion durch Amniocentese [Diagnostic possibilities of the function of the fetal thyroid gland by amniocentesis (author's transl.)]. Z Geburtshilfe Perinatol 1981; 185:96.

456 456. Perelman AH, Johnson RL, Clemons RD, et al. Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism. J Clin Endocrinol Metab 1990; 71:618.

457 457. Stoll C, Willard D, Czernichow P, et al. Prenatal diagnosis of primary pituitary dysgenesis. Lancet 1978; i:932.

458 458. Buscher U, Hertwig K, Dudenhausen JW. Nachweis von Erythropoietin im Fruchtwasser [Detection of erythropoietin in amniotic fluid]. Geburtshilfe Frauenheilkd 1996; 56:243.

459 459. Kakuya F, Shirai M, Takase M, et al. Relationship between erythropoietin levels both in cord serum and amniotic fluid at birth and abnormal fetal heart rate records. Pediatr Int 2002; 44:414.

460 460. Teramo KA, Widness JA. Increased fetal plasma and amniotic fluid erythropoietin concentrations: markers of intrauterine hypoxia. Neonatology 2009; 95:105.

461 461. Mikovic Z, Mandic V, Parovic V, et al. Erythropoietin in amniotic fluid as a potential marker in distinction between growth restricted and constitutionally small fetuses. J Matern Fetal Neonatal Med 2014; 27:1134.

462 462. Basbug M, Serin IS, Ozcelik B, et al. Correlation of elevated leptin levels in amniotic fluid and maternal serum in neural tube defects. Obstet Gynecol 2003; 101:523.

463 463. Bala RM, Wright C, Bardai A, et al. Somatomedin bioactivity in serum and amniotic fluid during pregnancy. J Clin Endocrinol Metab 1978; 46:649.

464 464. Gautray JP, Jolivet A, Vielh JP, et al. Presence of immunoassayable beta‐endorphin in human amniotic fluid: elevation in cases of fetal distress. Am J Obstet Gynecol 1977; 129:211.

465 465. Hankins GD, Rowe J, Quirk JG, Jr., et al. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis. Obstet Gynecol 1984; 64:353.

466 466. Szeto HH, Zervoudakis IA, Cederqvist LL, et al. Amniotic fluid transfer of meperidine from maternal plasma in early pregnancy. Obstet Gynecol 1978; 52:59.

467 467. Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204:314 e1.

468 468. Klotz U. The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokinet 2007; 46:271.

469 469. Jauniaux E, Gulbis B, Acharya G, et al. Maternal tobacco exposure and cotinine levels in fetal fluids in the first half of pregnancy. Obstet Gynecol 1999; 93:25.

470 470. Barr DB, Bishop A, Needham LL. Concentration of xenobiotic chemicals in the maternal–fetal unit. Reprod Toxicol 2007; 23:260.

471 471. Barr DB, Bishop A, Needham LL. Concentrations of xenobiotic chemicals in the maternal–fetal unit. Reprod Toxicol 2007; 23:260.

472 472. Ostrea EM, Jr., Matias O, Keane C, et al. Spectrum of gestational exposure to illicit drugs and other xenobiotic agents in newborn infants by meconium analysis. J Pediatr 1998; 133:513.

473 473. Bradman A, Barr DB, Claus Henn BG, et al. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 2003; 111: 1779.

474 474. Goh YI, Chudley AE, Clarren SK, et al. Development of Canadian screening tools for fetal alcohol spectrum disorder. Can J Clin Pharmacol 2008; 15:e344.

475 475. Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans‐3′‐hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 863:107.

476 476. Ostrea EM, Morales V, Ngoumgna E, et al. Prevalence of fetal exposure to environmental toxins as determined by meconium analysis. Neurotoxicology 2002; 23:329.

477 477. Custodio PJ, Carvalho ML, Nunes F, et al. Direct analysis of human blood (mothers and newborns) by energy dispersive X‐ray fluorescence. J Trace Elem Med Biol 2005; 19:151.

478 478. Turker G, Ergen K, Karakoc Y, et al. Concentrations of toxic metals and trace elements in the meconium of newborns from an industrial city. Biol Neonate 2006; 89:244.

479 479. Schmidt D, Achermann J, Odermatt B, et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007; 116:I64.

480 480. Sessarego N, Parodi A, Podesta M, et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008; 93:339.

481 481. Pozzobon M, Piccoli M, Schiavo AA, et al. Isolation of c‐Kit+ human amniotic fluid stem cells from second trimester. Methods Mol Biol 2013; 1035:191.

482 482. Vigeh M, Yokoyama K, Ramezanzadeh F, et al. Blood manganese concentrations and intrauterine growth restriction. Reprod Toxicol 2008; 25:219.

483 483. Osada H, Watanabe Y, Nishimura Y, et al. Profile of trace element concentrations in the feto‐placental unit in relation to fetal growth. Acta Obstet Gynecol Scand 2002; 81:931.

484 484. Sakamoto M, Kubota M, Murata K, et al. Changes in mercury concentrations of segmental maternal hair during gestation and their correlations with other biomarkers of fetal exposure to methylmercury in the Japanese population. Environ Res 2008; 106:270.

485 485. Ozdemir HS, Karadas F, Pappas AC, et al. The selenium levels of mothers and their neonates using hair, breast milk, meconium, and maternal and umbilical cord blood in Van Basin. Biol Trace Elem Res 2008; 122:206.

486 486. Tsutsumi O. Assessment of human contamination of estrogenic endocrine‐disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol 2005; 93:325.

487 487. Willhite CC, Ball GL, McLellan CJ. Derivation of a bisphenol A oral reference dose (RfD) and drinking water equivalent concentration. J Toxicol Environ Health B Crit Rev 2008; 11:69.

488 488. Ostrea EM, Jr., Bielawski DM, Posecion NC, Jr., et al. A comparison of infant hair, cord blood and meconium analysis to detect fetal exposure to environmental pesticides. Environ Res 2008; 106:277.

489 489. Blount BC, Valentin‐Blasini L. Biomonitoring as a method for assessing exposure to perchlorate. Thyroid 2007; 17:837.

490 490. Wessels D, Barr DB, Mendola P. Use of biomarkers to indicate exposure of children to organophosphate pesticides: implications for a longitudinal study of children's environmental health. Environ Health Perspect 2003; 111:1939.

491 491. Whyatt RM, Barr DB, Camann DE, et al. Contemporary‐use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environ Health Perspect 2003; 111:749.

492 492. Jarrell J, Chan S, Hauser R, et al. Longitudinal assessment of PCBs and chlorinated pesticides in pregnant women from Western Canada. Environ Health 2005; 4:10.

493 493. Kawashiro Y, Fukata H, Omori‐Inoue M, et al. Perinatal exposure to brominated flame retardants and polychlorinated biphenyls in Japan. Endocr J 2008; 55:1071.

494 494. Engel SM, Levy B, Liu Z, et al. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 2006; 21:110.

495 495. Mustafa AM, Malintan NT, Seelan S, et al. Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. Toxicol Appl Pharmacol 2007; 222:25.

496 496. Silva MJ, Reidy JA, Herbert AR, et al. Detection of phthalate metabolites in human amniotic fluid. Bull Environ Contam Toxicol 2004; 72:1226.

497 497. Huang PC, Kuo PL, Chou YY, et al. Association between prenatal exposure to phthalates and the health of newborns. Environ Int 2009; 35:14.

498 498. Milunsky A, Carmella SG, Ye M, et al. A tobacco‐specific carcinogen in the fetus. Prenat Diagn 2000; 20:307.

499 499. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004; 567:447.

500 500. Eyler FD, Behnke M, Wobie K, et al. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol 2005; 27:677.

501 501. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem 2007; 388:1455.

502 502. Sandberg JA, Olsen GD. Microassay for the simultaneous determination of cocaine, norcocaine, benzoylecgonine and benzoylnorecgonine by high‐performance liquid chromatography. J Chromatogr 1990; 525:113.

503 503. Mastrogiannis DS, Decavalas GO, Verma U, et al. Perinatal outcome after recent cocaine usage. Obstet Gynecol 1990; 76:8.

504 504. Abdeljaber M, Nolan BM, Schork MA. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 1990; 85:630.

505 505. Behnke M, Eyler FD, Garvan CW, et al. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 2001; 107:E74.

506 506. Addis A,Moretti ME, Ahmed Syed F, et al. Fetal effects of cocaine: an updated meta‐analysis. Reprod Toxicol 2001; 15:341.

507 507. Gouin K, Murphy K, Shah PS. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 2011; 204:340 e1.

508 508. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry 2000; 48:1032.

509 509. Loughhead AM, Fisher AD, Newport DJ, et al. Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry 2006; 163:145.

510 510. Omtzigt JG, Nau H, Los FJ, et al. The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, co‐medication, and the presence of spina bifida. Eur J Clin Pharmacol 1992; 43:381.

511 511. Lucas BR, Latimer J, Pinto RZ, et al. Gross motor deficits in children prenatally exposed to alcohol: a meta‐analysis. Pediatrics 2014; 134:e192.

512 512. Heller M, Burd L. Review of ethanol dispersion, distribution, and elimination from the fetal compartment. Birth Defects Res A Clin Mol Teratol 2014; 100: 277.

513 513. Feeley M, Brouwer A. Health risks to infants from exposure to PCBs, PCDDs and PCDFs. Food Addit Contam 2000; 17:325.

514 514. Yamada H, Furuta I, Kato EH, et al. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol 2002; 16:735.

515 515. Ikezuki Y, Tsutsumi O, Takai Y, et al. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002; 17:2839.

516 516. Jedeon K, De la Dure‐Molla M, Brookes SJ, et al. Enamel defects reflect perinatal exposure to bisphenol A. Am J Pathol 2013; 183:108.

517 517. Zoeller RT, Bansal R, Parris C. Bisphenol‐A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005; 146:607.

518 518. Whyatt RM, Barr DB. Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 2001; 109:417.

519 519. Fennell TR, Krol WL, Sumner SC, et al. Pharmacokinetics of dibutylphthalate in pregnant rats. Toxicol Sci 2004; 82:407.

520 520. Cruger DG, Bruun‐Petersen G, Kolvraa S. Early prenatal diagnosis: standard cytogenetic analysis of coelomic cells obtained by coelocentesis. Prenat Diagn 1996; 16:945.

521 521. Elejalde BR, de Elejalde MM, Acuna JM, et al. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis. Am J Med Genet 1990; 35:188.

522 522. Daniel A, Ng A, Kuah KB, et al. A study of early amniocentesis for prenatal cytogenetic diagnosis. Prenat Diagn 1998; 18:21.

523 523. Verma L, Macdonald F, Leedham P, et al. Rapid and simple prenatal DNA diagnosis of Down's syndrome. Lancet 1998; 352:9.

524 524. Pertl B, Kopp S, Kroisel PM, et al. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J Med Genet 1999; 36:300.

525 525. Lapidot‐Lifson Y, Lebo RV, Flandermeyer RR, et al. Rapid aneuploid diagnosis of high‐risk fetuses by fluorescence in situ hybridization. Am J Obstet Gynecol 1996; 174:886.

526 526. D'Alton ME, Malone FD, Chelmow D, et al. Defining the role of fluorescence in situ hybridization on uncultured amniocytes for prenatal diagnosis of aneuploidies. Am J Obstet Gynecol 1997; 176:769; discussion 74.

527 527. Kuo WL, Tenjin H, Segraves R, et al. Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet 1991; 49:112.

528 528. Ried T, Landes G, Dackowski W, et al. Multicolor fluorescence in situ hybridization for the simultaneous detection of probe sets for chromosomes 13, 18, 21, X and Y in uncultured amniotic fluid cells. Hum Mol Genet 1992; 1:307.

529 529. Klinger K, Landes G, Shook D, et al. Rapid detection of chromosome aneuploidies in uncultured amniocytes by using fluorescence in situ hybridization (FISH). Am J Hum Genet 1992; 51:55.

530 530. Ward BE, Gersen SL, Carelli MP, et al. Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens. Am J Hum Genet 1993; 52:854.

531 531. Divane A, Carter NP, Spathas DH, et al. Rapid prenatal diagnosis of aneuploidy from uncultured amniotic fluid cells using five‐colour fluorescence in situ hybridization. Prenat Diagn 1994; 14:1061.

532 532. Gersen SL, Carelli MP, Klinger KW, et al. Rapid prenatal diagnosis of 14 cases of triploidy using fish with multiple probes. Prenat Diagn 1995; 15:1.

533 533. Evans MI, Henry GP, Miller WA, et al. International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome specific probes and fluorescent in‐situ hybridization are used. Hum Reprod 1999; 14:1213.

534 534. Feldman B, Ebrahim SA, Hazan SL, et al. Routine prenatal diagnosis of aneuploidy by FISH studies in high‐risk pregnancies. Am J Med Genet 2000; 90:233.

535 535. Oneda B, Baldinger R, Reissmann R, et al. High‐resolution chromosomal microarrays in prenatal diagnosis significantly increase diagnostic power. Prenat Diagn 2014; 34:525.

536 536. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013; 122:1374.

537 537. Brady PD, Delle Chiaie B, Christenhusz G, et al. A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genet Med 2014; 16:469.

538 538. Donnenfeld AE, Lockwood D, Custer T, et al. Prenatal diagnosis from fetal urine in bladder outlet obstruction: success rates for traditional cytogenetic evaluation and interphase fluorescence in situ hybridization. Genet Med 2002; 4:444.

539 539. Ville YG, Nicolaides KH, Campbell S. Prenatal diagnosis of fetal malformations by ultrasound. In: Milunsky A, ed. Genetic disorders and the fetus: diagnosis, prevention, and treatment. Baltimore, MD: The Johns Hopkins University Press, 2004: 836.

540 540. Golden WL, Schneider BF, Gustashaw KM, et al. Prenatal diagnosis of Turner syndrome using cells cultured from cystic hygromas in two pregnancies with normal maternal serum alpha‐fetoprotein. Prenat Diagn 1989; 9:683.

541 541. Wax JR, Blakemore KJ, Soloski MJ, et al. Fetal ascitic fluid: a new source of lymphocytes for rapid chromosomal analysis. Obstet Gynecol 1992; 80:533.

542 542. Costa D, Borrell A, Margarit E, et al. Rapid fetal karyotype from cystic hygroma and pleural effusions. Prenat Diagn 1995; 15:141.

543 543. Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7:1.

544 544. van Dyke DL, Ebrahim SA, Al Saadi AA, et al. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988–2003. Prenat Diagn 2007; 27:583.

545 545. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370:799.

546 546. Grati FR, Malvestiti F, Ferreira JC, et al. Fetoplacental mosaicism: potential implications for false‐positive and false‐negative noninvasive prenatal screening results. Genet Med 2014; 16:620.

547 547. Wang JC, Sahoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med 2014.

548 548. Holbrook KA, Odland GF. The fine structure of developing human epidermis: light, scanning, and transmission electron microscopy of the periderm. J Invest Dermatol 1975; 65:16.

549 549. Holbrook KA, Odland GF. Regional development of the human epidermis in the first trimester embryo and the second trimester fetus (ages related to the timing of amniocentesis and fetal biopsy). J Invest Dermatol 1980; 74:161.

550 550. Tyden O, Bergstrom S, Nilsson BA. Origin of amniotic fluid cells in mid‐trimester pregnancies. Br J Obstet Gynaecol 1981; 88:278.

551 551. Gosden CM, Brock DJ. Morphology of rapidly adhering amniotic‐fluid cells as an aid to the diagnosis of neural tube defects. Lancet 1977; i:919.

552 552. Huisjes HJ. Cytology of the amniotic fluid and its clinical applications. In: Fairweather DVI, Eskes TKAB, eds. Amniotic fluid research and clinical applications, 2nd edn. Amsterdam: Elsevier/North Holland, 1978:93.

553 553. Bergström S. Ultrastructure of cell detachment from the human fetus in early pregnancy. Acta Obstet Gynecol Scand 1979; 58:353.

554 554. Schrage R, Bogelspacher HR, Wurster KG. Amniotic fluid cells in the second trimester of pregnancy. Acta Cytol 1982; 26:407.

555 555. Agorastos T, Bar T, Grussendorf EI, et al. Ultrastructural aspects of amniotic‐fluid cells: B. Vital cells. Z Geburtshilfe Perinatol 1982; 186:41.

556 556. Hoehn H, Bryant EM, Karp LE, et al. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. I. Clonal morphology and growth potential. Pediatr Res 1974; 8:746.

557 557. Felix JS, Doherty RA, Davis HT, et al. Amniotic fluid cell culture. I. Experimental design for evaluating cell culture variables: determination of optimal fetal calf serum concentration. Pediatr Res 1974; 8:870.

558 558. Polgar K, Adany R, Abel G, et al. Characterization of rapidly adhering amniotic fluid cells by combined immunofluorescence and phagocytosis assays. Am J Hum Genet 1989; 45:786.

559 559. Greenebaum E, Mansukhani MM, Heller DS, et al. Open neural tube defects: immunocytochemical demonstration of neuroepithelial cells in amniotic fluid. Diagn Cytopathol 1997; 16:143.

560 560. Medina‐Gomez P, McBride WH. Amniotic fluid macrophages fromnormal and malformed fetuses. Prenat Diagn 1986; 6:195.

561 561. Roberts SH, Little E, Vaughan M, et al. Rapid prenatal diagnosis of Patau's syndrome in a fetus with an abdominal wall defect by 72 hour culture of cells from amniotic fluid. Prenat Diagn 1993; 13:971.

562 562. Gosden C, Brock DJ. Amniotic fluid cell morphology in early antenatal prediction of abortion and low birth weight. Br Med J 1978; 2:1186.

563 563. Gosden CM. Amniotic fluid cell types and culture. Br Med Bull 1983; 39:348.

564 564. Osborn M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 1983; 48:372.

565 565. Franke WW, Appelhans B, Schmid E, et al. Identification and characterization of epithelial cells in mammalian tissues by immunofluorescence microscopy using antibodies to prekeratin. Differentiation 1979; 15:7.

566 566. Priest RE, Priest JH, Laundon CH, et al. Multinucleate cells incultures of human amniotic fluid form by fusion. Lab Invest 1980; 43:140.

567 567. Medina‐Gomez P, Johnston TH. Cell morphology in long‐term cultures of normal and abnormal amniotic fluids. Hum Genet 1982; 60:310.

568 568. Megaw JM, Priest JH, Priest RE, et al. Differentiation in human amniotic fluid cell cultures: II: Secretion of an epithelial basement membrane glycoprotein. J Med Genet 1977; 14:163.

569 569. Priest RE, Priest JH, Moinuddin JF, et al. Differentiation in human amniotic fluid cell cultures: I: Collagen production. J Med Genet 1977; 14:157.

570 570. Priest RE, Marimuthu KM, Priest JH. Origin of cells in human amniotic fluid cultures: ultrastructural features. Lab Invest 1978; 39:106.

571 571. Priest RE, Priest JH, Moinuddin JF, et al. Differentiation in human amniotic fluid cell cultures: chorionic gonadotropin production. In Vitro 1979; 15:142.

572 572. Thakar N, Priest RE, Priest JH. Estrogen production by cultured amniotic fluid cells. Clin Res 1982; 30:888A.

573 573. O'Shannessy DJ, Priest RE, Priest JH. Metabolism of [4‐14C]androstenedione by cells cultured from human amniotic fluid. J Steroid Biochem 1984; 20:935.

574 574. Laundon CH, Priest JH, Priest RE. The characterization of hCG regulation in cultured human amniotic fluid cells. Prenat Diagn 1981; 1:269.

575 575. Laundon CH, Priest JH, Priest RE. Characterization of hCG regulation in cultured human amniotic fluid cells: II. Mechanisms for stimulation. In Vitro 1983; 19:911.

576 576. Chang HC, Jones OW. In vitro characteristics of human fetal cells obtained from chorionic villus sampling and amniocentesis. Prenat Diagn 1988; 8:367.

577 577. Whitsett CF, Priest JH, Priest RE, et al. HLA typing of cultured amniotic fluid cells. Am J Clin Pathol 1983; 79:186.

578 578. Crouch E, Bornstein P. Collagen synthesis by human amniotic fluid cells in culture: characterization of a procollagen with three identical proalpha1(I) chains. Biochemistry 1978; 17:5499.

579 579. Crouch E, Bornstein P. Characterization of a type IV procollagen synthesized by human amniotic fluid cells in culture. J Biol Chem 1979; 254:4197.

580 580. Crouch E, Balian G, Holbrook K, et al. Amniotic fluid fibronectin. Characterization and synthesis by cells in culture. J Cell Biol 1978; 78:701.

581 581. Bryant EM, Crouch E, Bornstein P, et al. Regulation of growth and gene activity in euploid hybrids between human neonatal fibroblasts and epithelioid amniotic fluid cells. Am J Hum Genet 1978; 30:392.

582 582. Johnston P, Salk D, Martin GM, et al. Cultivated cells from mid‐trimester amniotic fluids: IV. Cell type identification via one and two‐dimensional electrophoresis of clonal whole cell homogenates. Prenat Diagn 1982; 2:79.

583 583. Virtanen I, von Koskull H, Lehto VP, et al. Cultured human amniotic fluid cells characterized with antibodies against intermediate filaments in indirect immunofluorescence microscopy. J Clin Invest 1981; 68:1348.

584 584. Cremer M, Treiss I, Cremer T, et al. Characterization of cells of amniotic fluids by immunological identification of intermediate‐sized filaments: presence of cells of different tissue origin. Hum Genet 1981; 59:373.

585 585. Chen WW. Studies on the origin of human amniotic fluid cells by immunofluorescent staining of keratin filaments. J Med Genet 1982; 19:433.

586 586. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31:11.

587 587. Ochs BA, Franke WW, Moll R, et al. Epithelial character and morphologic diversity of cell cultures from human amniotic fluids examined by immunofluorescence microscopy and gel electrophoresis of cytoskeletal proteins. Differentiation 1983; 24:153.

588 588. Hoehn H, Bryant EM, Karp LE, et al. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. II. Cytogenetic parameters as functions of clonal type and preparative technique. Clin Genet 1975; 7:29.

589 589. Regauer S, Franke WW, Virtanen I. Intermediate filament cytoskeleton of amnion epithelium and cultured amnion epithelial cells: expression of epidermal cytokeratins in cells of a simple epithelium. J Cell Biol 1985; 100:997.

590 590. Hsu LY, Kaffe S, Perlis TE. A revisit of trisomy 20 mosaicism in prenatal diagnosis – an overview of 103 cases. Prenat Diagn 1991; 11:7.

591 591. Van Dyke DL, Roberson JR, Babu VR, et al. Trisomy 20 mosaicism identified prenatally and confirmed in foreskin fibroblasts. Prenat Diagn 1989; 9:601.

592 592. Bell JE, Barron L, Raab G. Antenatal detection of neural tube defects: comparison of biochemical and immunofluorescence methods. Prenat Diagn 1994; 14:615.

593 593. Melancon SB, Lee SY, Nadler HL. Histidase activity in cultivated human amniotic fluid cells. Science 1971; 173:627.

594 594. Gerbie AB, Melancon SB, Ryan C, et al. Cultivated epithelial‐like cells and fibroblasts from amniotic fluid: their relationship to enzymatic and cytologic analysis. Am J Obstet Gynecol 1972; 114:314.

595 595. Van der Veer E, Kleijer WJ, de Josselin de Jong JE, Galjaard H. Lysosomal enzyme activities in different types of amniotic fluid cells measured by microchemical methods, combined with interference microscopy. Hum Genet 1978; 40:285.

596 596. Burton BK, Gerbie AB, Nadler HL. Biochemical and biological problems and pitfalls of cell culture for prenatal diagnosis. In: Milunsky A, ed. Genetic disorders and the fetus: diagnosis prevention, and treatment. New York: Plenum Press, 1979:369.

597 597. Hoehn H, Bryant EM, Fantel AG, et al. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. III. The fetal urine as a potential source of clonable cells. Humangenetik 1975; 29:285.

598 598. Chang HC, Jones OW. Amniocentesis: cell culture of human amniotic fluid in a hormone supplement. In: Sirbasku DA, Pardee AB, Sato GH, eds. Growth of cells in hormonally defined media (Cold Spring Harbor Conferences on Cell Proliferation). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982:1187.

599 599. Medina‐Gomez P, Bard JB. Analysis of normal and abnormal amniotic fluid cells in vitro by cinemicrography. Prenat Diagn 1983; 3:311.

600 600. Harris A. Glycoproteins that distinguish different cell types found in amniotic fluid. Hum Genet 1982; 62:188.

601 601. Felix JS, Sun TT, Littlefield JW. Human epithelial cells cultured from urine: growth properties and keratin staining. In Vitro 1980; 16:866.

602 602. von Koskull H, Aula P, Trejdosiewicz LK, et al. Identification of cells from fetal bladder epithelium in human amniotic fluid. Hum Genet 1984; 65:262.

603 603. Richkind KE, Risch NJ. Sensitivity of chromosomal mosaicism detection by different tissue culture methods. Prenat Diagn 1990; 10:519.

604 604. Hoehn HW. Fluid cell culture. In: Milunsky A, ed. Genetic disorders and the fetus, 4th edn. Baltimore, MD: The Johns Hopkins University Press, 1998: 128.

605 605. Kennerknecht I, Baur‐Aubele S, Grab D, et al. First trimester amniocentesis between the seventh and 13th weeks: evaluation of the earliest possible genetic diagnosis. Prenat Diagn 1992; 12:595.

606 606. Casey ML, Word RA, MacDonald PC. Endothelin‐1 gene expression and regulation of endothelin mRNA and protein biosynthesis in avascular human amnion. Potential source of amniotic fluid endothelin. J Biol Chem 1991; 266:5762.

607 607. Chang HC, Jones OW. Reduction of sera requirements in amniotic fluid cell culture. Prenat Diagn 1985; 5:305.

608 608. Liu L, Brinkman A, Blat C, et al. IGFBP‐1, an insulin like growth factor binding protein, is a cell growth inhibitor. Biochem Biophys Res Commun 1991; 174:673.

609 609. Priest JH, Rao KW. Prenatal chromosome diagnosis. In: Barch MJ, ed. The AGT cytogenetics laboratory manual, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 1997:199.

610 610. Schmid W. A technique for in situ karyotyping of primary amniotic fluid cell cultures. Humangenetik 1975; 30:325.

611 611. Hoehn H, Rodriguez ML, Norwood TH, et al. Mosaicism in amniotic fluid cell cultures: classification and significance. Am J Med Genet 1978; 2:253.

612 612. Boué J, Nicolas H, Barichard F, et al. Le clonage des cellules du liquide amniotique, aide dans l'interpretation des mosaiques chromosomiques en diagnostic prenatal. Ann Genet 1979; 22:3.

613 613. Hecht F, Peakman DC, Kaiser‐McCaw B, et al. Amniocyte clones for prenatal cytogenetics. Am J Med Genet 1981; 10:51.

614 614. Tabor A, Lind AM, Andersen AM, et al. A culture vessel for amniotic fluid cells allowing faster preparation of chromosome slides. Prenat Diagn 1984; 4:451.

615 615. Benn PA, Hsu LY. Maternal cell contamination of amniotic fluid cell cultures: results of a U.S. nationwide survey. Am J Med Genet 1983; 15:297.

616 616. Bui TH, Iselius L, Lindsten J. European collaborative study on prenatal diagnosis: mosaicism, pseudomosaicism and single abnormal cells in amniotic fluid cell cultures. Prenat Diagn 1984; 4 Spec No:145.

617 617. Worton RG, Stern R. A Canadian collaborative study of mosaicism in amniotic fluid cell cultures. Prenat Diagn 1984; 4 Spec No:131.

618 618. Batanian JR, Ledbetter DH, Fenwick RG. A simple VNTR‐PCR method for detecting maternal cell contamination in prenatal diagnosis. Genet Test 1998; 2:347.

619 619. Frederickson RM, Wang HS, Surh LC. Some caveats in PCR‐based prenatal diagnosis on direct amniotic fluid versus cultured amniocytes. Prenat Diagn 1999; 19:113.

620 620. Smith GW, Graham CA, Nevin J, et al. Detection of maternal cell contamination in amniotic fluid cell cultures using fluorescent labelled microsatellites. J Med Genet 1995; 32:61.

621 621. Claussen U, Schafer H, Trampisch HJ. Exclusion of chromosomal mosaicism in prenatal diagnosis. Hum Genet 1984; 67:23.

622 622. Sikkema‐Raddatz B, Castedo S, TeMeerman GJ. Probability tables for exclusion of mosaicism in prenatal diagnosis. Prenat Diagn 1997; 17:115.

623 623. American College of Medical Genetics. Standards and guidelines for clinical genetics laboratories, 2nd edn. Bethesda, MD: American College of Medical Genetics, 1999.

624 624. American College of Medical Genetics. Standards and guidelines for clinical genetics laboratories, 2008. https://www.acmg.net/ACMG/Medical-Genetics-Practice-Resources/Technical_Standards_and_Guidelines.aspx (accessed July 8, 2020).

625 625. Spurbeck JL, Zinsmeister AR, Meyer KJ, et al. Dynamics of chromosome spreading. Am J Med Genet 1996; 61:387.

626 626. Henegariu O, Heerema NA, Lowe Wright L, et al. Improvements in cytogenetic slide preparation: controlled chromosome spreading, chemical aging and gradual denaturing. Cytometry 2001; 43:101.

627 627. Spurbeck JL. The dynamics of chromosome spreading. Compact disk copyright 2013. Distributed by Association of Genetic Technologists (AGT), 2014.

628 628. Cheung SW, Spitznagel E, Featherstone T, et al. Exclusion of chromosomal mosaicism in amniotic fluid cultures: efficacy of in situ versus flask techniques. Prenat Diagn 1990; 10:41.

629 629. Featherstone T, Cheung SW, Spitznagel E, et al. Exclusion of chromosomal mosaicism in amniotic fluid cultures: determination of number of colonies needed for accurate analysis. Prenat Diagn 1994; 14:1009.

630 630. Cheng EY, Luthy DA, Dunne DF, et al. Is the 15‐in situ clone protocol necessary to detect amniotic fluid mosaicism? Am J Obstet Gynecol 1995; 173:1025.

631 631. Ing PS, van Dyke DL, Caudill SP, et al. Detection of mosaicism in amniotic fluid cultures: a CYTO2000 collaborative study. Genet Med 1999; 1:94.

632 632. American College of Medical Genetics. Standards and guidelines for clinical genetics laboratories. E4.1.3 amniotic fluid. Bethesda, MD: American College of Medical Genetics, 2006.

633 633. Miron PM. Preparation, culture, and analysis of amniotic fluid samples. Curr Protoc Hum Genet 2012: 8.4.

634 634. van Dyke DL, Roberson JR,Wiktor A. Prenatal cytogenetic diagnosis. In: McClatchey KD, ed. Clinical laboratory medicine, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2002:636.

635 635. Spurbeck JL, Carlson RO, Allen JE, et al. Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genet Cytogenet 1988; 32:59.

636 636. Carlan SJ, Papenhausen P, O'Brien WF, et al. Effect of maternal–fetal movement on concentration of cells obtained at genetic amniocentesis. Am J Obstet Gynecol 1990; 163:490.

637 637. Fischer RL, LaMotta J, McMorrow LE, et al. Effect of pre‐amniocentesis uterine manipulation on amniocyte concentration and culture duration: a randomized, clinical trial. Prenat Diagn 1996; 16:673.

638 638. Melnyk JH, Persinger G, Teplitz RLA. A micromethod for processing amniotic fluid cells. In Vitro 1979; 15:200.

639 639. Byrne DL, Marks K, Braude PR, et al. Amniofiltration in the first trimester: feasibility, technical aspects and cytological outcome. Ultrasound Obstet Gynecol 1991; 1:320.

640 640. Sundberg K, Smidt‐Jensen S, Lundsteen C, et al. Filtration and recirculation of early amniotic fluid. Evaluation of cell cultures from 100 diagnostic cases. Prenat Diagn 1993; 13:1101.

641 641. Sundberg K, Bang J, Brocks V, et al. Early sonographically guided amniocenteses with filtration technique: follow‐up on 249 procedures. J Ultrasound Med 1995; 14:585.

642 642. Sundberg K, Lundsteen C, Philip J. Early filtration amniocentesis for further investigation of mosaicism diagnosed by chorionic villus sampling. Prenat Diagn 1996; 16:1121.

643 643. Kunsela P, Seppala MB, Brock DJH, et al. Amniotic fluid fibronectin in normal pregnancy and in pregnancies with anencephalic fetus. Biomedicine 1978; 29:296.

644 644. Vlodavsky I, Voss R, Yarkoni S, et al. Stimulation of human amniotic fluid cell proliferation and colony formation by cell plating on a naturally produced extracellular matrix. Prenat Diagn 1982; 2:13.

645 645. Crickard K, Golbus MS. Influence of extracellular matrix on the proliferation of human amniotic fluid cells in vitro. Prenat Diagn 1982; 2:89.

646 646. Brackertz M, Kubbies M, Feige A, et al. Decreased oxygen supply enhances growth in culture of human midtrimester amniotic fluid cells. Hum Genet 1983; 64:334.

647 647. Held KR, Sönnichsen S. The effect of oxygen tension on colony formation and cell proliferation of amniotic fluid cells in vitro. Prenat Diagn 1984; 4:171.

648 648. Barnes D, Sato G. Serum‐free cell culture: a unifying approach. Cell 1980; 22:649.

649 649. Gospodarowicz D, Moran JS, Owashi ND. Effects of fibroblast growth factor and epidermal growth factor on the rate of growth of amniotic fluid‐derived cells. J Clin Endocrinol Metab 1977; 44:651.

650 650. Porreco RP, Bradshaw C, Sarkar S, et al. Enhanced growth of amniotic fluid cells in presence of fibroblast growth factor. Obstet Gynecol 1980; 55:55.

651 651. Art to Science. Freezing and thawing serum and other biological materials: optimal procedures minimize damage and maximize shelf‐life. HyClone Laboratories, Inc, 1992; 11:1.

652 652. Chang HC, Jones OW. A new growth medium for human amniotic fluid cells. Karyogram 1981; 7:54.

653 653. Chang HC, Jones OW, Masui H. Human amniotic fluid cells grown in a hormone‐supplemented medium: suitability for prenatal diagnosis. Proc Natl Acad Sci U S A 1982; 79:4795.

654 654. Biddle WC, Kuligowski S, Lockwood DH, et al. AmnioMAXTM‐C100: a new specialized cell culture medium for the propagation of human amniocytes. Focus 1992; 14:80.

655 655. Claussen U. The pipette method: a new rapid technique for chromosome analysis in prenatal diagnosis. Hum Genet 1980; 54:277.

656 656. Salk D, Disteche C, Stenchever MR, et al. Routine use of Chang medium for prenatal diagnosis: improved growth and increased chromosomal breakage. Am J Hum Genet 1983; 35:151A.

657 657. Masia A, Jenkins EC, Duncan C. Chromosomal abnormalities in cultures with Chang medium. Am J Hum Genet 1986; 39:260.

658 658. Krawczun MS, Jenkins EC, Masia A, et al. Chromosomal abnormalities in amniotic fluid cell cultures: a comparison of apparent pseudomosaicism in Chang and RPMI‐1640 media. Clin Genet 1989; 35:139.

659 659. Eiben B, Goebel R, Hansen S, et al. Early amniocentesis – a cytogenetic evaluation of over 1500 cases. Prenat Diagn 1994; 14:497.

660 660. Assel BG, Lewis SM, Dickerman LH, et al. Single operator comparison of early and mid‐second‐trimester amniocentesis. Obstet Gynecol 1992; 79:940.

661 661. Corning guide for identifying and correcting common cell growth problems. http://www.bioprocessonline.com/doc/identifying‐correcting‐cell‐growthproblems‐0001 (accessed May 19, 2015).

662 662. Persutte WH, Lenke RR. Failure of amniotic‐fluid cell growth: is it related to fetal aneuploidy? Lancet 1995; 345:96.

663 663. Elejalde BR, de Elejalde MM, Soto A. Amniotic‐fluid cell growth and fetal aneuploidy. Lancet 1995; 345:924.

664 664. Lam YH, Tang MH, Sin SY, et al. Clinical significance of amniotic‐fluid‐cell culture failure. Prenat Diagn 1998; 18:343.

665 665. American College of Medical Genetics Standards and Guidelines for Clinical Genetics Laboratories. https://www.acmg.net/ACMG/Medical-Genetics-Practice-Resources/Technical_Standards_and_Guidelines.aspx (accessed July 8, 2020).

666 666. Milunsky A, Bender CS. Failure of amniotic‐fluid cell growth with toxic tubes. N Engl J Med 1979; 301:47.

667 667. Kohn G. Failure of amniotic fluid cell cultures due to syringe toxicity. Prenat Diagn 1981; 1:233.

668 668. Chiesa J, Bureau JP. Nothing ventured, nothing gained! Prenat Diagn 1999; 19:894.

669 669. Seguin LR, Palmer CG. Variables influencing growth and morphology of colonies of cells from human amniotic fluid. Prenat Diagn 1983; 3:107.

670 670. Felix JS, Doherty RA. Amniotic fluid cell culture II. Evaluation of a red blood cell lysis procedure for culture of cells from blood‐contaminated amniotic fluid. Clin Genet 1979; 15:215.

671 671. Johansson KE, Bolske G. Evaluation and practical aspects of the use of a commercial DNA probe for detection of mycoplasma infections in cell cultures. J Biochem Biophys Methods 1989; 19:185.

672 672. Knutsen T. Laboratory safety, quality control and regulations. In: Barch MJ, ed. The AGT cytogenetics laboratory manual, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 1997:597.

673 673. Holtge GA. Laboratory safety. In: McClatchey KD, ed. Clinical laboratory medicine, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2002:78.

674 674. Travers EM. Basic laboratory management. In: McClatchey KD, ed. Clinical laboratory medicine, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2002:3.

675 675. Tsai MS, Lee JL, Chang YJ, et al. Isolation of human multipotent mesenchymal stem cells from second‐trimester amniotic fluid using a novel two‐stage culture protocol. Hum Reprod 2004; 19:1450.

676 676. De Coppi P, Bartsch G, Jr., Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100.

677 677. Guillot PV, Gotherstrom C, Chan J, et al. Human first trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007; 25:646.

678 678. Roubelakis MG, Pappa KI, Bitsika V, et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 2007; 16:931.

679 679. Zhou J,Wang D, Liang T, et al. Amniotic fluid‐derived mesenchymal stem cells: characteristics and therapeutic applications. Arch Gynecol Obstet 2014; 290:223.

680 680. In't Anker PS, Scherjon SA, Kleijburg‐van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102:1548.

681 681. Trounson A. A fluid means of stem cell generation. Nat Biotechnol 2007; 25:62.

682 682. Liu YW, Roan JN, Wang SP, et al. Xenografted human amniotic fluid‐derived stem cell as a cell source in therapeutic angiogenesis. Int J Cardiol 2013; 168:66.

683 683. Petsche Connell J, Camci‐Unal G, Khademhosseini A, et al. Amniotic fluid‐derived stem cells for cardiovascular tissue engineering applications. Tissue Eng Part B Rev 2013; 19:368.

684 684. Kang NH, Hwang KA, Kim SU, et al. Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid‐derived stem cells. Cancer Gene Ther 2012; 19:517.

685 685. Kaviani A, Perry TE, Dzakovic A, et al. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 2001; 36:1662.

686 686. Gucciardo L, Lories R, Ochsenbein‐Kolble N, et al. Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG 2009; 116:166.

687 687. Murphy SV, Atala A. Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells. Semin Reprod Med 2013; 31:62.